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ABSTRACT 
The integrity and stability of DNA is essential to life since it stores genetic 
information in every living cell. Chemicals from the environment will assault DNA to 
form various types of DNA damage, ranging from small covalent crosslinks between 
neighboring DNA bases as seen in cyclobutane pyrimidine dimers, to big bulky adducts 
derived from benzo[a]pyrene. This resultant damage will lead to replication block and 
mutation if remain unrepaired and will eventually cause cancer or other genetic diseases. 
The work presented in this dissertation has illustrated the important role of the AlkB 
family DNA repair enzymes in cancer and Wilson’s Disease. In addition, we discovered 
these enzymes can modify epigenetic markers that affect DNA regulation. We also 
studied sequence-dependent conformational heterogeneity of aminobiphenyl adduct on 
DNA replication. 
The AlkB family DNA repair enzyme is a family of α-ketoglutarate (αKG)- and 
non-heme iron-dependent dioxygenases. Among all the homologs in this family, human 
ALKBH2 and ALKBH3, and E. coli AlkB have been proved to be the major enzymes 
that directly remove the alkyl adducts from alkylated DNA bases like 3-methylcytosine 
(3mC) and 1-methyladenine (1mA). These DNA adducts will cause strong replication 
block and mutagenicity in cell if AlkB enzymes are suppressed by toxicants. Cancer-
associated mutations often lead to perturbed cellular energy metabolism and 
accumulation of potentially harmful oncometabolites. Chiral molecule 2-
hydroxyglutarate (2HG) and its two stereoisomers (D- and L-2HG) have been 
demonstrated to competitively inhibit several αKG- and iron-dependent dioxygenases, 
including ALKBH2 and ALKBH3. In this work, we carried out detailed kinetic analyses 
  
of DNA repair reactions catalyzed by ALKBH2, ALKBH3 and the bacterial AlkB in 
the presence of D- and L-2HG in both double and single stranded DNA contexts. We 
not only determined kinetic parameters of inhibition, including kcat, KM, and Ki, but also 
correlated the relative concentrations of 2HG and αKG previously measured in tumor 
cells with the inhibitory effect of 2HG on the AlkB family enzymes. Both D- and L-
2HG significantly inhibited the human DNA repair enzymes ALKBH2 and ALKBH3 
under pathologically relevant concentrations (73-88% for D-2HG and 31-58% for L-
2HG inhibition). This work provides a new perspective that the elevation of either D- 
or L-2HG in cancer cells may contribute to an increased mutation rate by inhibiting the 
DNA repair carried out by the AlkB family enzymes and thus exacerbate the genesis 
and progression of tumors.   
Another type of inhibitor of AlkB is toxic metals, such as, copper. Disturbed 
metabolism of copper ions can cause diseases, such as Wilson’s disease (WD).  In this 
work, we investigated the inhibitory effect of Cu(II) ion on the AlkB family DNA repair 
enzymes, include human ALKBH2, ALKBH3, and E. coli AlkB proteins.  None of the 
three proteins were significantly inhibited under normal cellular copper concentrations.  
But under WD related condition, we observed the activities of all three enzymes were 
strongly suppressed (inhibition from 95.2 to 100.0%).  We also noted the repair 
efficiency under ds-DNA condition is less susceptible than ss-DNA to the inhibition.    
AlkB can repair many alkylated DNA bases including 3mC, 1mA, 3-
metheylthymine, 1-methylguanine, ethenoadenine and ethenocytosine. But in this work, 
we found a new DNA base substrate for AlkB, 5-Methylcytosine (5mC). 5mC in DNA 
CpG islands is an important epigenetic biomarker for mammalian gene regulation. It is 
  
oxidized to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-
carboxylcytosine (5caC) by the ten-eleven translocation (TET) family enzymes, which 
are also α-KG/Fe(II)-dependent dioxygenases. In this work, we demonstrate that the 
epigenetic marker 5mC is biochemically modified to 5hmC, 5fC, and 5caC by 
ALKBH2, ALKBH3, and AlkB. Theoretical calculations indicate that these enzymes 
may bind 5mC in the syn-conformation, placing the methyl group comparable to 3-
methylcytosine, the prototypic substrate of AlkB. This is the first demonstration of the 
AlkB proteins to oxidize a methyl group attached to carbon, instead of nitrogen, on a 
DNA base. These observations suggest a broader role in epigenetics for these DNA 
repair proteins. 
Besides alkyl DNA adducts, there are bulky DNA adducts existing in human. Bulky 
organic carcinogens are activated in vivo and subsequently react with nucleobases of 
cellular DNA to produce adducts. Some of these DNA adducts exist in multiple 
conformations that are slowly interconverted to one another. Different conformations 
could contribute to different mutagenic and repair outcomes. Unfortunately, studies on 
the conformation-specific inhibition of replication, which is more relevant to cell 
survival, are scarce; this is presumably due to difficulties in studying the structural 
dynamics of DNA lesions at the replication fork. It is challenging to capture the exact 
nature of replication inhibition by traditional end-point assays, since they usually detect 
either the ensemble of consequences of all the conformers or the culmination of all 
cellular behaviors, such as mutagenicity or survival rate. One article reported an unusual 
sequence-dependent conformational heterogeneity involving FABP-modified (4′-
fluoro-4-aminobiphenyl) DNA under different sequence contexts. There were 67% B-
  
type (B) conformation and 33% stacked (S) conformation in TG1*G2T sequence; 
whereas, 100% B conformation was observed in TG1G2*T sequence. In this study, we 
applied primer extension assay to compare the inhibition models between these two 
FABP-modified DNA sequences. We utilized a combination of surface plasmon 
resonance (SPR) and HPLC-based steady-state kinetics to reveal the differences in 
terms of binding affinity and inhibition with polymerase between these two conformers 
(67%B:33%S and 100%B). The conformational heterogeneities from these two 
sequences lead to different types of inhibition on replication. 
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ABSTRACT 
Cancer-associated mutations often lead to perturbed cellular energy metabolism and 
accumulation of potentially harmful oncometabolites.  One example is the chiral 
molecule 2-hydroxyglutarate (2HG); its two stereoisomers (D- and L-2HG) have been 
found with abnormally high concentrations in tumors featuring anomalous metabolic 
pathways.  2HG has been demonstrated to competitively inhibit several α-ketoglutarate 
(αKG)- and non-heme iron-dependent dioxygenases, including some of the AlkB family 
DNA repair enzymes, such as ALKBH2 and ALKBH3.  However, previous studies have 
only provided the IC50 values of D-2HG on the enzymes and the results have not been 
correlated to physiologically relevant concentrations of 2HG and αKG in cancer cells.  
In this work, we carried out detailed kinetic analyses of DNA repair reactions catalyzed 
by ALKBH2, ALKBH3 and the bacterial AlkB in the presence of D- and L-2HG in both 
double and single stranded DNA contexts.  We determined kinetic parameters of 
inhibition, including kcat, KM, and Ki.  We also correlated the relative concentrations of 
2HG and αKG previously measured in tumor cells with the inhibitory effect of 2HG on 
the AlkB family enzymes.  Both D- and L-2HG significantly inhibited the human DNA 
repair enzymes ALKBH2 and ALKBH3 under pathologically relevant concentrations 
(73-88% for D-2HG and 31-58% for L-2HG inhibition).  This work provides a new 
perspective that the elevation of either D- or L-2HG in cancer cells may contribute to 
an increased mutation rate by inhibiting the DNA repair carried out by the AlkB family 
enzymes and thus exacerbate the genesis and progression of tumors.   
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INTRODUCTION 
Mutations in the isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) are frequently 
found in >75% human low grade glioma, secondary glioblastoma, cartilaginous tumor 
and >20% of acute myeloid leukemia.1–5  Tumor-derived mutant forms of IDH catalyze 
the NAD-dependent dehydrogenation of α-ketoglutarate (αKG) to D-2-
hydroxyglutarate (D-2HG), a function that supplants the physiological activity of IDH, 
which entails reductive decarboxylation of isocitrate to αKG (Figure 1b).6–13  L-2HG, 
the stereoisomer of D-2HG,  has been identified as an oncometabolite with elevated 
concentrations in renal cell carcinoma9,10 neurodegenerative disorders,14,15 and in tissues 
under oxygen limitation or hypoxic conditions.11,12  The elevation of L-2HG under such 
conditions is key from either loss of expression of L-2HG dehydrogenase or 
promiscuous substrate utilization by lactate dehydrogenase A and malate 
dehydrogenases 1 and 2.10,12  Both D-2HG (R-2HG) and L-2HG (S-2HG) and several 
other molecules have been identified as oncometabolites because their accumulations in 
different tumor cells are originated from dysregulated energy metabolism pathways and 
metabolic imbalance.16–20  Because of their structural similarity to αKG, both D- and L-
2HG could compete with αKG and inhibit enzymatic processes that use αKG as a 
substrate.  One important class of enzymes that utilizes αKG—and thus potentially 
susceptible to inhibition by 2HG—is the non-heme iron- and αKG-dependent 
dioxygenases, a family of enzymes with over 80 different members.21–24  2HG has been 
demonstrated to inhibit several αKG-dependent enzymes, such as histone demethylases, 
prolyl hydroxylases, the TET family 5-methlycytosine (5mC) hydroxylases,7 and  some 
of the AlkB family DNA repair enzymes, such as ALKBH2 and ALKBH3.8,25  However, 
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in the case of the AlkB proteins, previous in vitro studies have only provided the IC50 
values of 2HG on the enzymes and the results have not been extrapolated to 
physiologically relevant concentrations of 2HG and αKG in cancer cells.  While Wang 
et al. demonstrated that the accumulation of DNA damage in cells producing high levels 
of D-2HG is consistent with inhibition of ALKBH2 and/or ALKBH3,25 the detailed 
mechanism of inhibition of the AlkB enzymes by 2HG has not been reported.  A careful 
study of the inhibitory effect of both D- and L-2HG on AlkB repair enzymes is needed 
to quantify the extent of inhibition of the direct reversal DNA repair pathways; 
perturbations in these pathways would lead to unrepaired mutagenic DNA lesions, 
which would cause mutations that can accelerate tumor progression or enable metastatic 
growth.  Such a study would also facilitate the identification of druggable targets related 
to the AlkB enzymes because many alkylating chemotherapeutic agents generate DNA 
adducts that are repaired by this family of repair enzymes.26  Inhibition of these enzymes 
would thus afford a clinical benefit in anti-tumor regimens. 
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Figure 1. a) Repair mechanism of the AlkB family enzymes on alkyl DNA lesions.  
Adduct m1A is used here as an example to show the steps of enzymatic catalysis.  b) 
The generation of D- and L-2HG and mechanisms of inhibition to the AlkB family DNA 
repair enzymes. 
 
The Escherichia coli AlkB protein was discovered to be an αKG/Fe(II)-dependent 
dioxygenase that oxidizes the alkyl groups in DNA adducts formed by alkylation agents, 
ultimately restoring the undamaged DNA bases (Figure 1a).27–29   Nine human homologs 
of AlkB have been identified as ALKBH1-8 and FTO.29,30   Among these homologs, 
ALKBH231–36 and ALKBH337–40 have been identified as major DNA repair enzymes 
for repairing small alkyl DNA lesions.  Since the initial discovery of the catalytic 
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mechanism of AlkB in 2002,27,28 a range of alkyl adducts have been identified as 
substrates for AlkB, ALKBH2 and ALKBH3, both in vitro and in vivo.24  The adducts 
include all of the seven N-methyl adducts occurring at the Watson-Crick (W-C) base-
pairing face of the four nucleobases.41  The seven adducts include 3-methylcytosine 
(m3C), N4-methylcytosine, 1-methyladenine (m1A), N6-methyladenine, 3-
methylthymine, 1-methylguanine, and N2-methylguanine.  AlkB has also been reported 
to repair other DNA adducts, such as 1,N6-ethenoadenine, 1,N6-ethanoadenine, 3,N4-
ethenocytosine, 3-ethylcytosine, 1,N2-ethenoguanine, 3,N4-α-hydroxyethanocytosine, 
3,N4-α-hydroxypropanocytosine, N2-ethylguanine, N2-tetrahydrofuran-2-yl-
methylguanine, N2-furan-2-yl-methylguanine, malondialdehydeguanine, α-
hydroxypropanoguanine, and γ-hydroxypropanoguanine.41–49   The repair efficiency and 
substrate scope of the AlkB family enzymes have been recently reviewed in 
detail.24,30,50–54 
In this work, we carried out kinetic analyses of DNA repair reactions catalyzed by 
ALKBH2, ALKBH3 and AlkB in the presence of the inhibitors D- and L-2HG.  
Oligonucleotides containing the methylated bases m1A and m3C were selected as 
substrates for the repair reactions because they are most efficiently repaired by these 
three enzymes.24  For each substrate/enzyme/inhibitor combination, we determined a 
complete panel of kinetic parameters, (kcat, KM, kcat/KM, Ki), and correlated the relative 
concentrations of 2HG and αKG found in tumor cells with the inhibitory effect of 2HG 
on the AlkB family enzymes.  Because ALKBH2 preferentially repairs adducts in 
double stranded (ds) DNA and ALKBH3 prefers to repair lesions in a single stranded 
(ss) DNA context, we tested the three repair enzymes with both ds and ss DNA 
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substrates.  This is the first report of 2HG inhibition of AlkB family DNA repair 
evaluated in both single- and double- stranded DNA.  We also developed an HPLC-
based method to study DNA repair in the ds-DNA.  The results showed that both 
ALKBH2 and ALKBH3, the major mammalian direct reversal repair enzymes for 
alkylated DNA damage, were significantly inhibited by D- and L-2HG under 
pathophysiologically relevant conditions. 
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EXPERIMENTAL PROCEDURES 
Oligonucleotide Synthesis.  Sixteen-mer oligonucleotides were synthesized with the 
sequence 5’-GAAGACCTXGGCGTCC-3’ containing the lesions m1A and m3C at the 
X position.43,55  The complementary 23mer oligonucleotides were synthesized with the 
sequence of 5′-CTGGGACGCCYAGGTCTTCACTG-3′, where Y represents the 
position incorporating the regular bases T or G, and named as 23mer-Tcp or 23mer-Gcp.  
The 23mer oligonucleotides complementary to 23mer-Tcp and 23mer-Gcp were also 
synthesized, with the sequence 5′-CAGTGAAGACCTZGGCGTCCCAG-3′, where Z 
was the regular base A or C, named as 23mer-A or 23mer-C.  All DNA syntheses 
employed solid-phase phosphoramidite chemistry performed on a MerMade-4 
Oligonucleotide Synthesizer.55  The oligonucleotides were purified by HPLC (Thermo 
Fisher Scientific) on a DNAPac PA-100 Semi-Preparative column (Phenomenex).  
Solvent A was 100 mM 1:1 triethylamine-acetic acid (TEAA) in water and solvent B 
was 100% acetonitrile.  The concentration of DNA was determined by UV absorbance 
at 260nm by NanoDrop.  The oligonucleotides were characterized by HPLC-
electrospray ionization triple quadrupole time of flight mass spectrometry (AB Sciex) 
(Table S1).   
Expression and Purification of the AlkB, ALKBH2 and ALKBH3 Proteins.  
ALKBH2, ALKBH3 and AlkB were expressed and purified as described and shown 
previously.47,55  In the following section, AlkB is used as an example to illustrate the 
purification protocols.  Briefly, His-tagged AlkB was obtained by transforming 
pET28a-AlkB into E. coli Rosetta2(DE3)pLysS or BL21(DE3)pLysS cells and protein 
expression was induced by the addition of 1mM isopropyl-b-D-thiogalactopyranoside 
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(IPTG) at 37 ℃ (37 ℃ for ALKBH2 and 30 ℃ for ALKBH3).  The expressed protein 
was purified by affinity chromatography.  Thrombin was used to digest His-tag 
containing AlkB protein.  The final purified protein was stored -80 °C in AlkB storage 
buffer as previously described.55 
Enzymatic Reaction. To assay the AlkB family demethylase activity toward the two 
substrates in ss- and ds-DNA, the enzymatic reactions were performed at 37 °C at 
different time points for the kinetic study of the AlkB reaction in buffer [70.0 μM 
Fe(NH4)2(SO4)2·6H2O, 0.93 mM αKG (0.1 mM for 2-HG inhibition assay), 1.86 mM 
ascorbic acid and 46.5 mM HEPES (pH 8.0)].  The reactions were stopped by adding 
10 mM EDTA followed by heating at 95 °C for 5 min.   Typically, the purified proteins 
were incubated with oligonucleotides containing DNA adducts in the presence of all 
cofactors in a 20 μL reaction volume.  In order to separate substrate and product, 16mer 
m1A and A or 16mer m3C and C, the HPLC condition started with a 5 min gradient of 
1.5 M ammonium acetate from 50% to 65%, followed by 2 min 70% ammonium acetate.  
The column was DNApac PA-100 (4× 250 mm) (Thermo Scientific).  The UV detection 
wavelength was at 260 nm.  Each reaction was carried out in triplicate. 
For the double-stranded DNA substrates, 1.5 equivalents of the 23mer complementary 
oligonucleotides, 23mer-Tcp or 23mer-Gcp, were annealed with 16mer oligos by 
heating the mixture at 80 °C for 10 min and then cooling down to room temperature 
with the rate of 1 °C/10 s.  The post-reaction treatments were similar to those for the ss-
DNA reactions, except 1.75 equivalents of 23mer-A and 23mer-C were added together 
with 10 mM EDTA followed by heating up to 95 °C  for 10 min and then cooled down 
 13 
 
to room temperature with the same rate as used for annealing.  The quantification 
method was the same as described above.  Each reaction was carried out in triplicate.  
Kinetic Studies.  To determine KM, kcat and Ki values for the repair reactions, initial 
rates were obtained by keeping the DNA substrate and enzyme concentration constant 
and varying αKG concentration with or without various concentrations of D- or L-2HG 
(0, 1.0, 3.0, 5.0, 7.0, 9.0, 37.3 mM).  All reactions were performed at 37 °C in triplicate 
and the data were analyzed by GraphPad Prism 5 with the Michaelis-Menten kinetics 
model.  The inhibition curves were fit to the equation: 
1/V0=1/Vmax+(KM/Vmax)×(1+[I]/Ki)×(1/[S]). 
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RESULTS 
To test the inhibitory effect of D- and L-2HG on the AlkB family enzymes, we first 
chemically synthesized oligonucleotides by site-specifically incorporating m1A and 
m3C, the major substrates of the AlkB family enzymes.24,43  We also expressed and 
purified recombinant human ALKBH2 and ALKBH3 proteins, and the E. coli AlkB 
protein.55  Then, we performed kinetic experiments to determine the kcat and KM of the 
three enzymes as they repair the two adducts in both ds- and ss-DNA.  After that, we 
measured the Ki of D- and L-2HG on the repair reactions, and finally evaluated the 
inhibitory effect of the oncometabolites in the concentration range reported to occur in 
certain human cancers.   
Oligonucleotide Synthesis and Protein Purification.  Two 16mer oligonucleotides 
containing m1A and m3C were chemically synthesized with the sequence 5’-
GAAGACCTXGGCGTCC-3’ (X denotes the alkylated base).43  After HPLC 
purification, the identity of the oligonucleotides was confirmed by comparing the 
theoretical m/z of the oligonucleotides with the observed m/z from high resolution LC-
MS (Table S1).  The genes for E. coli AlkB and its human homologs ALKBH2 and 
ALKBH3 were cloned into pET28a+ expression vector; the incorporation of the correct 
sequences was confirmed by sequencing the corresponding plasmids.  The three 
proteins were then expressed in E. coli hosts, isolated and purified by affinity 
chromatography as described in Experimental Section.55  
Enzymatic Assay for Measuring Kinetic Constants.  For each enzymatic reaction, 
the adduct-containing oligonucleotide was incubated with the necessary cofactors for 
the AlkB reaction: Fe(II), αKG, and ascorbic acid (see Experimental Section) in either 
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ss- or ds-DNA.  Below, m1A will be used as an example to explain the HPLC analyses.  
For the ss-DNA reactions, the starting material 16mer m1A (1.5 min in Figure 2a) and 
product 16mer A (2.8 min in Figure 2b) were well separated by anion exchange HPLC, 
and the amount of each was quantified by reference to standard curves.  For ds-DNA 
repair reactions, we initially used a 16mer complementary oligonucleotide.  However, 
the dsDNA of starting material (16mer complementary plus 16mer m1A) and the 
dsDNA of product (16mer complementary plus 16mer A) could not be fully separated 
under various HPLC conditions, thus making the quantification of reactions challenging.  
Therefore, we adopted a longer complementary oligonucleotide (23mer Tcp, 5.6 min in 
Figure 2c), which provided a similar repair efficiency as the 16mer complementary 
oligonucleotide.  In the analysis of the 23mer reaction, the dsDNA of starting material 
(23mer Tcp plus16mer m1A, 7.5min in Figure 2c) and the dsDNA of product (23mer 
Tcp plus 16mer A, 7.7min in Figure 2c) still could not be fully separated under the 
HPLC condition.  Consequently, we designed another 23mer oligonucleotide that was 
fully complementary to 23mer Tcp (23mer A, 5.5min in Figure 2d).  After the dsDNA 
reaction with 23mer Tcp, 23mer A was added to the reaction mixture, and the mixture 
was heated to 80 °C for 10 min and then slowly cooled down to room temperature.  The 
addition of 23mer A allowed the 23mer Tcp formed perfect dsDNA with 23mer A (9.1 
min in Figure 2d), thus releasing 16mer m1A and 16mer A from their previous 
complementarity with 23mer Tcp.  Under these conditions, the 16mer m1A and 16mer 
A in the dsDNA repair reaction were well separated and quantified by the HPLC 
analyses (Figure 2d).  A similar analytical strategy was successfully applied to m3C 
dsDNA repair reactions. 
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Figure 2. HPLC analyses of the DNA repair reactions.  a) Starting material 16mer 
oligonucleotide containing m1A at the lesion site in ss-DNA reaction.  b) ss-Product 
16mer oligonucleotide containing A at the “lesion site” in the ss-DNA reaction.  c) ds-
DNA reaction products of 16mer m1A with 23mer Tcp.  The mixture containing ss-
16mer m1A, ss-16mer A, ds-16mer m1A:23mer Tcp, and ds-16mer A:23mer Tcp.  The 
latter two species were not fully separable by HPLC.  d) ds-DNA reaction products of 
16mer m1A with 23mer Tcp and additional 23mer A, which is fully complementary to 
23mer Tcp.  The duplex of 23mer Tcp:23mer A was eluted as ds-DNA, thus releasing 
ss-16mer m1A and ss-16mer A for quantification.  
 
Kinetic Analyses.  After setting up a reliable procedure to quantify the conversion of 
the repair reactions, we carried out systematic kinetic analyses of the AlkB family 
enzymes repairing m1A and m3C.  Because the purpose of this work was to measure 
the possible inhibition of D- and L-2HG on the repair reactions catalyzed by αKG-
dependent AlkB family enzymes, the kinetic parameters of αKG in the repair reactions 
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were first measured.  In a typical kinetic analysis (e.g., ALKBH2 repairing m1A), 5 µM 
of oligonucleotide substrate, and 0.2 µM ALKBH2 enzyme were mixed with different 
concentrations of αKG (5.0-70.0 µM) and the extent of the repair reaction was 
quantified at different time points (see Experimental section for details).  Because the 
repair of one molecule m1A to A requires the conversion of one molecule of αKG to 
succinate (Figure 1), the concentrations of the product 16mer A were used to calculate 
the kcat and KM of αKG.  To ensure that the kinetic parameters reflect initial velocity, 
the DNA and enzyme concentrations were optimized to make sure the conversion of the 
repair reactions was less than 20%.  All reactions were carried out in triplicate.   
For ALKBH2 repair of m1A in ds-DNA (Table 1, Table S2, and Figure S1), the kcat of 
αKG was 2.5 ± 0.1 min-1 and the KM was 7.3 ± 0.9 µM, which are comparable to the 
literature reported kinetics parameters of other αKG dependent enzymes.7,25,56–61 The 
kcat/KM value of ds-repair reaction (0.34 min-1·µM-1) shows that the repair was more 
efficient than in ss-DNA (0.28 min-1·µM-1), which agrees with the literature on the 
reported strand preference of ALKBH2.59  The kinetic data of ALKBH2 repair of m3C 
showed a similar trend (Table 1, Table S2, Table S4 and Figure S2).  In contrast to 
ALKBH2’s preference for ds-DNA substrates, the kinetic parameters of ALKBH3 
repair of ds-DNA substrates could not be measured due to the low conversion ratio even 
with very high enzyme loading, such as 5.0 µM of ALKBH3 to 5.0 µM substrate.  
Conversely, ALKBH3 could efficiently repair both DNA adducts in ss-DNA (Table 1).  
These results confirm the previously reported preference of ALKBH3’s repair of ss-
DNA substrates.48,55  The kinetic factors of the E. coli AlkB protein were also measured 
and the kcat and KM values agreed well with the literature reported kcat and KM of the 
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reactions (Table 1, Table S2 and S3, and Figure S3 and S4).59,60  The kcat/KM values of 
AlkB repair confirm that the enzyme prefers to repair m1A and m3C in ss-DNA as 
compared with ds-DNA.55    
 
Table 1. Kinetic constants of αKG as a substrate on ALKBH2, ALKBH3 and AlkB 
repair reactions. 
Enzyme Condition KM [µM] kcat [min-1] kcat/KM [min-1·µM-1] 
ALKBH2 
ss-m1A 4.1 ± 0.9 1.1 ± 0.1 0.28 
ds-m1A 7.3 ± 0.9 2.5 ± 0.1 0.34 
ss-m3C 1.4 ± 0.2 1.7 ± 0.1 1.20 
ds-m3C 1.9 ± 0.4 2.6 ± 0.1 1.34 
ALKBH3 
ss-m1A 2.3 ± 0.1 1.2 ± 0.0 0.51 
ss-m3C 1.9 ± 0.4 1.7 ± 0.0 0.87 
AlkB 
ss-m1A 7.1 ± 1.1 4.2 ± 0.2 0.59 
ds-m1A 12.7 ± 1.3 4.8 ± 0.2 0.38 
ss-m3C 19.9 ± 1.3 24.5 ± 0.7 1.23 
ds-m3C 10.8 ± 1.9 8.2 ± 0.4 0.76 
 
2HG Inhibition of the DNA Repair Reactions Catalyzed by the AlkB Family 
Enzymes.  With reliable kcat and KM parameters of the three enzymes, we set out to 
measure the Ki values of D-2HG and L-2HG together with a positive control, N-
oxalylglycine (N-OG), a commonly used inhibitor of αKG dependent enzymes.7  
Because D-2HG and L-2HG are chiral molecules, polarimetry (P-2000 Digital 
Polarimeter, JASCO Inc.) was utilized to measure their optical activity in a 1 decimeter 
cell.  The optical rotation of D-2HG was +9.5° (c = 1.0, 0.1M NaOH), which agreed 
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well to the value provided by the commercial source ([α]/D +8.5±1.5°, c = 1.0 in NaOH, 
Sigma-Aldrich Co LLC.).  Similarly, the optical rotation of L-2HG was -8.0°, which 
was consistent with the reported -8.5±1.5° value.  These values confirm the chirality 
and purity of the two enantiomers.    
For the inhibition of the ALKBH2 repair reaction on m1A in ds- and ss-DNA, the Ki 
values for D-2HG are 280 ± 61 μM and 405 ± 61 μM, respectively (Table 2, Figure 3a 
and 3b, Table S5).  These data indicate that D-2HG has a stronger binding affinity for 
the complex of ALKBH2 with ds-DNA than ss-DNA.  For L-2HG reactions, the Ki 
values are similar but smaller (stronger inhibition) than with the corresponding D-2HG 
reactions (Table 2, Figure 3d and 3e, Table S5).  The Ki values of N-OG show much 
stronger inhibition (with about 10 times more potency, Table 2) of all repair reactions 
with the Ki values ranging from 6 to 40 μM.  For the inhibition of ALKBH3, a similar 
trend was observed for each individual reaction for the Ki values: D-2HG > L-2HG > 
N-OG (Table 2).  For the inhibition of AlkB-catalyzed reactions, there is no clear trend 
in the inhibitory potency between the D- and L-2HG; N-OG, however, is a stronger 
inhibitor than either of 2HG isomers.  We also measured the IC50 of D- and L-2HG on 
the three enzymes (Table S7); in general, the IC50 values correlate well with the Ki 
values.  
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Table 2: Inhibition constant (Ki) of D-2HG, L-2HG and N-OG.  The individual 
inhibition reactions were depicted in Figure S6 to S15. 
Enzyme Condition 
Ki [μM] 
D-2HG L-2HG N-OG 
ALKBH2 
ss-m1A 405 ± 61 275 ± 41 30 ± 7 
ds-m1A 280 ± 61 180 ± 36 16 ± 5 
ss-m3C 152 ± 13 64 ± 3 40 ± 7 
ds-m3C   79 ± 11 76 ± 11 7 ± 2 
ALKBH3 
ss-m1A 545 ± 77 185 ± 23 27 ± 4 
ss-m3C 490 ± 46 228 ± 16 37 ± 3 
AlkB 
ss-m1A 571 ± 166 337 ± 99 0.4 ± 0.1 
ds-m1A 529 ± 126 598 ± 173 2.0 ± 1.3 
ss-m3C 447 ± 113 276 ± 111 0.4 ± 0.1 
ds-m3C 230 ± 55 308 ± 108 0.2 ± 0.0 
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Figure 3. Inhibition of ALKBH2 repair of m1A in ss- and ds-DNA by D- and L-2HG.  
a) Inhibition of D-2HG on m1A repair in ss-DNA.  b) Inhibition of D-2HG on m1A 
repair in ds-DNA.  c) Inhibition of D-2HG on m1A repair under D-2HG:αKG = 373:1 
ratio conditions.  d) Inhibition of L-2HG on m1A repair in ss-DNA.  e) Inhibition of L-
2HG on m1A repair in ds-DNA.  f) Inhibition of L-2HG on m1A repair under L-
2HG:αKG = 28:1 ratio conditions.   
 
To make our experiments more relevant with regard to the anticipated cellular 
concentrations of metabolites/oncometabolites observed in human tumors, we also 
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evaluated the extent inhibition of the ALKBH2 and ALKBH3 repair reactions by 
varying the ratios of D- or L-2HG to αKG.  For D-2HG inhibition, we tested a ratio of 
concentrations for D-2HG:αKG = 373:1, which was observed in glioma patients with 
IDH mutations (detailed information see the Discussion section).6  The concentration of 
αKG was fixed at 100 µM to make sure that the kinetic analyses reflected steady state 
catalysis (Figure S5).  We found that the repair efficiencies of ALKBH2 and ALKBH3 
were 73-88% inhibited under such conditions, (Figure 3c, Table 3).  For L-2HG 
inhibition, we tested a ratio of L-2HG:αKG= 28:1, which was reported in patients with 
kidney cancers (see Discussion section).10  We found 48-58% of ALKBH2 and 31-40% 
of ALKBH3’s activity was inhibited under this condition.  These results suggest that 
the strong inhibition on DNA repair observed in the in vitro experiments may also occur 
in tumor cells of cancer patients. 
 
Table 3. Inhibition ratio of D-2HG (373 fold to αKG) and L-2HG (28 fold to αKG) on 
ALKBH2 and ALKBH3. 
Enzyme Condition % Inhibition of 373-fold D-2H to αKG  
% Inhibition of 28-fold 
L-2HG to αKG  
ALKBH2 
ss-m1A 86 53 
ds-m1A 77 57 
ss-m3C 88 48 
ds-m3C 88 58 
ALKBH3 
ss-m1A 80 40 
ds-m1A 81 37 
ss-m3C 73 32 
ds-m3C 87 31 
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αKG Recovery of 2HG’s Inhibition on the Repair Enzymes.  Because 2-HG and 
αKG are structurally similar, researchers hypothesized that 2HG is able to replace αKG 
in the active site of αKG dependent enzymes and competitively inhibit their enzymatic 
activities.7  Crystal structures of histone demethylases show that D-2HG binds to the 
same site as αKG in the catalytic center.7  We tested the competition between 2HG and 
αKG in the DNA repair reactions.  Using ALKBH2 repair of m1A as an example, the 
repair ratios without adding 2HG were controlled to be around 60% under different αKG 
concentrations (0.1, 0.5 and 1.0 mM, Figure 4 and Table S6).  For the inhibition 
reactions, D-2HG was added at a fixed concentration (10 mM) in the reaction mixture, 
which contained ALKBH2 and necessary cofactors.  Then, different concentrations of 
αKG were added and mixed.  After that the reaction was initiated by adding the 
oligonucleotide substrates.  When 0.1 mM αKG was present, the conversion decreased 
to 22%.  When 0.5 mM and 1.0 mM αKG were added, the repair ratio increased to 35% 
and 38%, respectively (Figure 4 and Table S6).  This observed trend of reactivity 
recovery is consistent with the notion that D-2HG acts as a competitive inhibitor in the 
αKG-dependent DNA repair reactions.7  Similar recovery patterns were observed for all 
other D- and L-2HG inhibition reactions on all three enzymes (Figure 4 and Table S6).  
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Figure 4. Addition of αKG reverses the inhibitory effect of 2-HG toward ALKBH2 
repair of m1A.  Different concentrations of αKG were added to a fixed concentration of 
2HG (10 mM) to recover the repair of m1A by a) ALKBH2, b) ALKBH3 and c) AlkB.   
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DISCUSSION 
Biological Implications of 2HG Inhibition of DNA Repair Enzymes.  In the current 
study, we have shown that both D- and L-enantiomers of the oncometabolite 2HG can 
significantly inhibit the human DNA repair enzymes ALKBH2 and ALKBH3 under 
physiologically relevant concentrations.  The concentrations of D-2HG and αKG on 
average in glioma cells are 15.5 µmol/g, and 0.0415 µmol/g, respectively, which 
correspond to a concentration ratio between D-2HG and αKG of 373 to 1.6,7   Under this 
ratio condition, the repair activities of ALKBH2 and ALKBH3 were 73-88% inhibited 
(Table 3).  The concentrations of L-2HG and αKG on average in kidney cancer cells are 
1.15 µmol/g and 0.0484 µmol/g, respectively, which corresponds to a concentration 
ratio between L-2HG and αKG of 28 to 1.10  Under this ratio condition, ALKBH2 and 
ALKBH3’s repair activities are 31-58% inhibited (Table 3).  Although the relative 
concentration of L-2HG (1.15 µmol/g) is more than 10 times lower than D-2HG (15.5 
µmol/g), the ALKBH2 and ALKBH3 enzymes are still soundly inhibited by L-2HG 
partially due to the higher binding affinity of L-2HG (i.e., lower Ki) than D-2HG (Table 
2).  The extent of inhibition in both cases was measured when the concentration of αKG 
was fixed at 100 µM, to ensure steady state catalysis.  However, at lower concentrations 
of αKG, (i.e., 50 or 20 µM), the efficiency of adduct repair decreased even further.  The 
cellular concentrations of αKG are typically around 40 to 50 µM (0.0415 and 0.0484 
µmol/g or mM) in cancer patients,6,10 which are near to the 50-100 µM range used in 
our experiments.  Our data also show that, consistent with competitive inhibition of 
2HG, the inhibition activity in the repair reaction reflects primarily the ratio between 
2HG and αKG.  ALKBH2 and ALKBH3 are enzymes that repair alkyl DNA damage; 
 26 
 
hence, inhibition of DNA repair leads to alkylation product accumulation, less cellular 
survival, and increased mutations, which affect the resistance/sensitivity balance to 
alkylating chemotherapeutics.  The elevation of both D- and L-2HG in cancer cells may 
contribute to the increased mutation rate and exacerbate tumorigenesis and progression.    
Strand Preference of the Three Repair Enzymes.  According to the literature, 
ALKBH2 prefers to repair m1A and m3C in ds-DNA, whereas ALKBH3 and AlkB 
prefer to repair those adducts in ss-DNA.24,30,55  We tested the repair activity in both ss-
DNA and ds-DNA substrates in this study.  The experimental results reported in this 
paper provide a strong kinetic basis for the previous observations.  For ALKBH2, the 
kcat/KM values of ds-repair are higher than the repair in ss-DNA (Table 1).  By contrast, 
the kcat/KM values of AlkB repair are higher for ss-DNA substrates than for ds-DNA 
substrates (Table 1).  For ALKBH3, we were only able to measure the kinetic 
parameters for ss-repair, as the ds-repair reactions were too inefficient to evaluate.  
These results agree with and add quantitative detail to previous observations that 
ALKBH3 strongly prefers to repair adducts in ss-DNA. 
Other αKG/Fe(II)-Dependent Enzymes may be Inhibited by Oncometabolites.  
There are about 80 proteins in the αKG/Fe(II)-dependent enzyme family, including  jmjc, 
prolyl hydroxylase, TET, and the AlkB family enzymes.21–23  Studies have demonstrated 
that D- and L-2HG inhibit jmjc and TET family proteins.7,62  In addition to 2HG,  
intermediates in the TCA cycle such as succinate and fumarate have also been found to 
exhibit higher-than-normal concentrations in different cancer cells (Figure 1b).18  Given 
their structural similarities to αKG and 2HG, these metabolites could also perturb αKG-
dependent enzymatic activities in the cell, especially DNA repair processes that are 
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related to the AlkB family enzymes.  Systematic studies are needed to explore these 
possibilities and correlate these biochemical results with clinical observations.  These 
studies are also pivotal for the design and development of therapeutic agents that target 
the abnormal metabolic pathways of cancer.      
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Figure S9. Inhibition of ALKBH2-mediated ds-m3C repair by D-2HG, L-2HG and N-
OG.   
Figure S10. Inhibition of ALKBH3-mediated ss-m1A repair by D-2HG, L-2HG and N-
OG.   
Figure S11. Inhibition of ALKBH3-mediated ss-m3C repair by D-2HG, L-2HG and N-
OG.   
Figure S8. Inhibition of ALKBH2-mediated ds-m1A repair by D-2HG, L-2HG and N-
OG.   
Figure S9. Inhibition of ALKBH2-mediated ds-m3C repair by D-2HG, L-2HG and N-
OG.   
Figure S10. Inhibition of ALKBH3-mediated ss-m1A repair by D-2HG, L-2HG and N-
OG.   
Figure S11. Inhibition of ALKBH3-mediated ss-m3C repair by D-2HG, L-2HG and N-
OG.   
Figure S12. Inhibition of AlkB-mediated ss-m1A repair by D-2HG, L-2HG and N-OG.   
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Figure S13. Inhibition of AlkB-mediated ss-m3C repair by D-2HG, L-2HG and N-OG.  
Figure S14. Inhibition of AlkB-mediated ds-m1A repair by D-2HG, L-2HG and N-OG.   
Figure S15. Inhibition of AlkB-mediated ds-m3C repair by D-2HG, L-2HG and N-OG. 
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Table S1. Calculated and observed molecular weight (MW) and m/z value of 
oligonucleotides used in the enzymatic reactions.  The sequence of the 16mer 
oligonucleotides was 5’-GAAGACCTXGGCGTCC-3’, where X indicates m1A or 
m3C. The sequence of the complementary 23mer oligonucleotides was 5′-
CTGGGACGCCYAGGTCTTCACTG-3′, where Y represents the position opposite the 
lesion site and contains the canonical bases T and G; these molecules were named 23-
Tcp and 23-Gcp, respectively.  Additionally, 23mer oligonucleotides complementary to 
23-Tcp and 23-Gcp were also synthesized with the sequence 5′-
CAGTGAAGACCTZGGCGTCCCAG-3′, where Z denotes the regular bases A and C, 
and named 23-A and 23-C, respectively. 
Oligonucleotide MW (calculated) of neutral species 
m/z (calculate) 
-4 charge peak 
m/z (observed) 
-4 charge peak 
16mer m1A 4902.88 1224.71 1224.71 
16mer m3C 4878.87 1218.71 1218.70 
Oligonucleotide MW (calculated) of neutral species 
m/z (calculate) 
-5 charge peak 
m/z (observed) 
-5 charge peak 
23mer Tcp 7028.19 1404.63 1404.66 
23mer Gcp 7053.19 1409.63 1409.66 
23mer A 7055.22 1410.04 1410.06 
23mer C 7031.21 1405.23 1405.26 
 
  
 45 
 
Table S2. Initial rate for kinetic studies of ALKBH2, ALKBH3 and AlkB on αKG as a 
substrate under different conditions.  The reaction rate is in µM/min. 
αKG (μM) 
ALKBH2  reaction Rate 
αKG (μM) 
ALKBH2 reaction Rate 
ss-m1A ds-m1A ss-m3C ds-m3C 
5.0 0.10 ± 0.00 0.16 ± 0.01 1.0 0.14 ± 0.00 0.10 ± 0.01 
10.0 0.11 ± 0.01 0.21 ± 0.03 3.0 0.22 ± 0.00 0.15 ± 0.01 
20.0 0.14 ± 0.01 0.26 ± 0.03 5.0 0.29 ± 0.02 0.18 ± 0.03 
30.0 0.15 ± 0.00 0.30 ± 0.02 10.0 0.30 ± 0.02 0.21 ± 0.02 
50.0 0.16 ± 0.02 0.32 ± 0.03 20.0 0.32 ± 0.01 0.23 ± 0.02 
70.0  0.35 ± 0.03 30.0 0.32 ± 0.03 0.25 ± 0.02 
αKG (μM) 
ALKBH3 reaction rate 
ss-m1A ss-m3C 
5 0.20 ± 0.02 0.24 ± 0.00 
10 0.24 ± 0.01 0.29 ± 0.01 
20 0.26 ± 0.01 0.30 ± 0.01 
30 0.28 ± 0.01 0.30 ± 0.02 
50 0.28 ± 0.01 0.32 ± 0.01 
70 0.28 ± 0.02 0.33 ± 0.01 
αKG (μM) 
AlkB reaction rate 
ss-m1A ds-m1A ss-m3C ds-m3C 
5.0 0.17  ± 0.01 0.20 ± 0.02 0.31 ± 0.03 0.46  ± 0.04 
10.0 0.25  ± 0.01 0.32 ± 0.05 0.49 ± 0.05 0.53  ± 0.04 
20.0 0.30  ± 0.03 0.44 ± 0.02 0.75 ± 0.09 0.78  ± 0.07 
30.0 0.35  ± 0.02 0.51 ± 0.02 0.87 ± 0.13 0.92  ± 0.04 
50.0 0.34  ± 0.04 0.60 ± 0.01 1.04 ± 0.10 0.99  ± 0.09 
70.0 0.39  ± 0.04 0.59 ± 0.04 1.17 ± 0.12 1.09  ± 0.06 
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Table S3. Initial rate for kinetic studies of ALKBH2 and ALKBH3 on DNA adducts as 
substrates.  
ALKBH2 reaction rate 
ss-
m1A 
(μM) 
V0 
(μM/min) 
ds-
m1A 
(μM) 
V0 
(μM/min) 
ss-
m3C 
(μM) 
V0 
(μM/min) 
ds-
m3C 
(μM) 
V0 
(μM/min) 
7.5 0.31 ± 0.02 5 0.26 ± 0.05 2.5 0.18 ± 0.01 2.5 0.22 ± 0.02 
10 0.36 ± 0.03 7.5 0.34 ± 0.03 3.5 0.20 ± 0.01 5 0.25 ± 0.02 
12.5 0.49 ± 0.02 10 0.41 ± 0.04 4.5 0.24 ± 0.02 7.5 0.30 ± 0.01 
15 0.53 ± 0.05 12.5 0.47 ± 0.04 5.5 0.25 ± 0.02 10 0.37 ± 0.04 
17.5 0.53 ± 0.08 15 0.52 ± 0.10 6.5 0.27 ± 0.02 12.5 0.41 ± 0.02 
20 0.66 ± 0.03 17.5 0.53 ± 0.09 7.5 0.31 ± 0.04 15 0.42 ± 0.03 
ALKBH3 reaction rate       
ss-
m1A 
(μM) 
V0 
(μM/min) 
ss-
m3C 
(μM) 
V0 
(μM/min) 
    
7.5 0.30 ± 0.02 5 0.22 ± 0.01     
10 0.33 ± 0.02 7.5 0.24 ± 0.01     
12.5 0.35 ± 0.03 10 0.25 ± 0.01     
15 0.36 ± 0.02 12.5 0.27 ± 0.01     
17.5 0.37 ± 0.02 15 0.26 ± 0.01     
20 0.38 ± 0.03 17.5 0.28 ± 0.01     
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Table S4. Kinetic constants of ALKBH2 and ALKBH3 reactions on DNA adducts as 
substrates. 
Enzyme Substrate KM [µM] kcat [min-1] kcat / KM [min-1·µM-1] 
ALKBH2 
ss-m1A 35.9 ± 18.2 8.9 ± 3.2 0.25 
ds-m1A 12.6 ± 1.4 9.3 ± 0.5 0.74 
ss-m3C 4.4 ± 1.1 2.4 ± 0.3 0.53 
ds-m3C 5.0 ± 1.5 5.5 ± 0.6 1.10 
ALKBH3 
ss-m1A 3.5 ± 0.2 1.8 ± 0.0 0.52 
ss-m3C 1.9 ± 0.5 1.2 ± 0.1 1.03 
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Table S5. 2-HG inhibition on ALKBH2 demethylation of ss- and ds-m1A. 
D-2HG inhibition on ALKBH2 demethylation of ss-m1A. 
 0.0 1.0 3.0 5.0 9.0 
3 1.23 ± 0.07 1.07 ± 0.06 0.80 ± 0.03 0.61 ± 0.05 0.47 ± 0.04 
6 1.43 ± 0.07 1.22 ± 0.07 0.93 ± 0.05 0.69 ± 0.05 0.55 ± 0.02 
9 1.50 ± 0.06 1.29 ± 0.07 0.99 ± 0.04 0.70 ± 0.02 0.57 ± 0.04 
12 1.67 ± 0.06 1.44 ± 0.05 1.11 ± 0.04 0.82 ± 0.04 0.63 ± 0.03 
15 1.78 ± 0.08 1.51 ± 0.08 1.18 ± 0.03 0.89 ± 0.04 0.70 ± 0.03 
 
D-2HG inhibition on ALKBH2 demethylation of ds-m1A 
 0.0 1.0 3.0 5.0 9.0 
5 1.54 ± 0.04 1.20 ± 0.08 0.85 ± 0.02 0.59 ± 0.07 0.37 ± 0.15 
8 1.68 ± 0.11 1.43 ± 0.03 0.96 ± 0.02 0.74 ± 0.12 0.44 ± 0.10 
11 1.67 ± 0.01 1.55 ± 0.19 1.06 ± 0.22 0.81 ± 0.13 0.52 ± 0.02 
14 1.85 ± 0.01 1.59 ± 0.13 1.08 ± 0.11 0.82 ± 0.11 0.52 ± 0.06 
 
D-2HG inhibition on ALKBH2 demethylation of ss-m1A and ds-m1A under 373 fold 
to αKG condition. 
 
0.0 9.0 37.3 
ss-m1A 93.9 ± 6.4 37.2 ± 1.5 12.7 ± 0.1 
ds-m1A 97.7 ± 1.6 37.8 ± 2.8 22.3 ± 0.8 
 
D-2HG 
    /mM 
Product 
/μM 
Time/min 
D-2HG 
    /mM Product 
/μM 
Time/min 
D-2HG 
    /mM 
Repair                                     
       ratio % 
Substrate 
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L-2HG inhibition on ALKBH2 demethylation of ss-m1A 
 0.0 1.0 3.0 5.0 9.0 
3 1.34 ± 0.05 0.82 ± 0.03 0.54 ± 0.02 0.43 ± 0.03 0.34 ± 0.03 
6 1.61 ± 0.05 1.04 ± 0.03 0.67 ± 0.01 0.53 ± 0.05 0.44 ± 0.00 
9 1.62 ± 0.04 1.13 ± 0.08 0.72 ± 0.02 0.59 ± 0.02 0.46 ± 0.01 
12 1.84 ± 0.09 1.28 ± 0.07 0.85 ± 0.02 0.68 ± 0.01 0.53 ± 0.01 
15 1.96 ± 0.09 1.33 ± 0.07 0.92 ± 0.04 0.73 ± 0.02 0.54 ± 0.03 
 
L-2HG inhibition on ALKBH2 demethylation of ds-m1A 
 0.0 1.0 3.0 5.0 9.0 
5 2.21 ± 0.14 1.19 ± 0.09 0.67 ± 0.07 0.48 ± 0.05 0.38 ± 0.04 
8 2.56 ± 0.13 1.74 ± 0.03 0.95 ± 0.03 0.61 ± 0.06 0.43 ± 0.02 
11 2.84 ± 0.22 2.05 ± 0.12 1.12 ± 0.07 0.79 ± 0.08 0.51 ± 0.03 
14 2.94 ± 0.03 2.18 ± 0.08 1.04 ± 0.31 0.85 ± 0.03 0.54 ± 0.03 
 
L-2HG inhibition on ALKBH2 demethylation of ss-m1A and ds-m1A under 28 fold to 
αKG condition. 
 
0.0 1.0 2.8 
ss-m1A 80.8 ± 0.9 55.1 ± 2.9 38.3 ± 0.5 
ds-m1A 85.0 ± 1.2 65.1 ± 2.0 37.0 ± 0.5 
 
 
L-2HG 
    /mM Product 
/μM 
 Time/min 
L-2HG 
    /mM Product 
/μM 
Time/min 
L-2HG 
    /mM 
Repair                                    
       ratio % 
Substrate 
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Table S6. Addition of αKG reverses the inhibitory effect of 2HG toward ALKBH2, 
ALKBH3 and AlkB. Both D-2HG and L-2HG concentrations were fixed at 10.0 mM. 
 
ALKBH2 ALKBH3 AlkB 
No 
inhibitor 
D-
2HG 
L-
2HG 
No 
inhibitor 
D-
2HG 
L-
2HG 
No 
inhibitor 
D-
2HG 
L-
2HG 
0.1 mM 61.5± 1.5 
22.0± 
0.7 
10.9± 
0.5 
60.0± 
1.3 
37.0± 
0.6 
20.9± 
1.1 
66.0± 
0.2 
24.2± 
0.4 
30.2± 
1.5 
0.5 mM 66.0± 0.6 
35.1± 
0.8 
21.5± 
0.6 
59.4± 
0.1 
43.3± 
0.9 
34.2± 
1.9 
65.8± 
0.3 
29.2± 
1.1 
36.9± 
1.7 
1.0 mM 63.9± 0.5 
38.1± 
1.1 
25.5± 
0.4 
57.9± 
1.6 
46.6± 
2.2 
39.2± 
0.6 
65.0± 
0.3 
29.0± 
0.7 
40.2± 
2.6 
 
Table S7: IC50 (50% inhibition concentration) of L-2HG, D-2HG and N-OG on 
ALKBH2, ALKBH3 and AlkB. 
Enzyme Adduct 
IC50 [mM] 
D-2HG L-2HG N-OG 
ALKBH2 
ss-m1A 10.3 ± 1.6 7.0 ± 1.1 0.8 ± 0.2 
ds-m1A 4.7 ± 0.8 2.7 ± 0.5 0.2 ± 0.1 
ss-m3C 10.9 ± 1.0 4.6 ± 0.2 2.9 ± 0.5 
ds-m3C 4.2 ± 0.6 4.1 ± 0.6 0.4 ± 0.1 
ALKBH3 
ss-m1A 24.3 ± 3.5 8.3 ± 1.0 1.2 ± 0.2 
ss-m3C 26.4 ± 2.5 12.3 ± 0.8 2.0 ± 0.2 
AlkB 
ss-m1A 8.6 ± 2.5 5.1± 1.5 6.7E-03±1.5E-03 
ds-m1A 4.7 ± 1.1 5.3 ± 1.5 1.8E-02±1.1E-02 
ss-m3C 2.7 ± 0.7 1.7 ± 0.7 2.3E-03±0.6E-03 
ds-m3C 2.4 ± 0.6 3.2 ± 1.1 1.7E-03±0.3E-03 
 
 
Group Repair                                     
      ratio% 
αKG 
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Figure S1. Steady-state kinetic studies probing the influence of αKG on adduct 
demethylation reactions catalyzed by ALKBH2.  Data are in Table S2. 
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Figure S2. Steady-state kinetic studies probing the influence of αKG on adduct 
demethylation reactions catalyzed by ALKBH3.  Data are in Table S2. 
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Figure S3. Steady-state kinetic studies probing the influence of αKG on adduct 
demethylation reactions catalyzed by AlkB.  Data are in Table S2. 
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Figure S4. Steady-state kinetic studies probing the influence of adducts in the 
demethylation reactions catalyzed by ALKBH2 and ALKBH3. Data are in Table S3. 
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Figure S5. The repair percentage of AlkB on ss-m1A under various concentrations of 
αKG.  Y-axis represents the percentage conversion of starting material m1A to product 
A. 
 
  
 
Figure S6. Inhibition of ALKBH2-mediated ss-m1A repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG.   
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Figure S7. Inhibition of ALKBH2-mediated ss-m3C repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG.   
 
  
 
Figure S8. Inhibition of ALKBH2-mediated ds-m1A repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG.   
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Figure S9. Inhibition of ALKBH2-mediated ds-m3C repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG. 
 
   
 
Figure S10. Inhibition of ALKBH3-mediated ss-m1A repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG. 
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Figure S11. Inhibition of ALKBH3-mediated ss-m3C repair by D-2HG, L-2HG and N-
OG.  Left: D-2HG, middle: L-2HG and right: N-OG. 
 
  
 
Figure S12. Inhibition of AlkB-mediated ss-m1A repair by D-2HG, L-2HG and N-OG.  
Left: D-2HG, middle: L-2HG and right: N-OG. 
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Figure S13. Inhibition of AlkB-mediated ss-m3C repair by D-2HG, L-2HG and N-OG.  
Left: D-2HG, middle: L-2HG and right: N-OG. 
  
 
Figure S14. Inhibition of AlkB-mediated ds-m1A repair by D-2HG, L-2HG and N-OG.  
Left: D-2HG, middle: L-2HG and right: N-OG. 
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Figure S15. Inhibition of AlkB-mediated ds-m3C repair by D-2HG, L-2HG and N-OG.  
Left: D-2HG, middle: L-2HG and right: N-OG. 
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ABSTRACT 
Disturbed metabolism of copper ions can cause diseases, such as Wilson’s disease 
(WD).  In this work, we investigated the inhibitory effect of Cu(II) ion on the AlkB 
family DNA repair enzymes, which are members of the Fe(II)/αKG-dependent 
dioxygenase and includes human ALKBH2, ALKBH3, and E. coli AlkB proteins.  None 
of the three proteins were significantly inhibited under normal cellular copper 
concentrations.  But under WD related condition, we observed the activities of all three 
enzymes were strongly suppressed (inhibition from 95.2 to 100.0%).  We also noted the 
repair efficiency under ds-DNA condition is less susceptible than ss-DNA to the 
inhibition.    
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Copper is an essential yet toxic metal for human physiological functions and the cellular 
concentrations of its ions, such as Cu(II) and Cu(I) ions, are tightly regulated.  If the 
concentrations of these ions are dysregulated, certain diseases, such as Wilson’s disease 
(WD), may occur.1,2  For patients under WD condition, the level of copper in human 
liver samples raises as much as 249.9 ng/mg (dry weight), which is significantly higher 
(more than 10 fold) than the level in normal cells (21.5 ng/mg).1  These elevated copper 
levels create an inflammatory cellular environment in liver tissue cells and damage their 
lipid bilayers, thus forming a variety of DNA adducts.  Nair et. al have reported the 
ethenoadenine (eA) and ethenocytosine (eC) DNA lesions are significantly increased 
under WD condition.1,3  These etheno DNA lesions are substrates of the AlkB family 
DNA repair enzymes, such as the human homologs ALKBH2 and 3, which use an 
Fe(II)/alpha-ketoglutarate (αKG)-dependent mechanism to oxidize the abnormal alkyl 
groups, ultimately restoring the undamaged DNA bases.4  Previously, the copper(II) ion 
has been reported to replace the Fe(II) ion in AlkB in a spectroscopic study, and to 
inhibit several Fe(II)/αKG family enzymes, such as JMJD2A, JMJD2E and PHD2.5–7  
Several divalent ions, such as Ni2+, Co2+ and Mn2+, have been demonstrated to inhibit 
other enzymes in this family, such as C-P4H, PLOD1, FIH, TauD, JMJD1A and 
ALKBH2.5,8  It is reasonable to predict, then, that the high level of copper ions 
accumulated under WD condition inhibits the DNA repair capacity of both ALKBH2 
and 3. Therefore the elevated level of copper ions found in WD condition induces 
damages and increases the number of etheno adducts within the cell in a “two-fold” 
manner; it not only induces alkyl DNA damage through lipid peroxidation but also 
suppresses the repair of those adducts from the AlkB family DNA repair enzymes.  
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The AlkB protein in E. coli was discovered to be an Fe(II)/αKG- dependent dioxygenase 
that repairs various alkyl DNA lesions (Figure 1).9,10  Nine human homologs of AlkB 
have been identified as ALKBH1-8 and FTO.  Among these homologs, ALKBH2 and 
ALKBH3 have been characterized as DNA repair proteins.11,12  A variety of alkyl DNA 
lesions have been proven as substrates for AlkB, ALKBH2 and ALKBH3, both in vitro 
and in vivo.  The lesions include methyl adducts, like 3-methylcytosine (m3C) and 1-
methyladenine, etheno adducts, such as eA and eC, and other lesions with complex alkyl 
modifications to the DNA bases.12  Among those adducts, m3C and m1A have been 
reported as the best substrates for the AlkB family enzymes.11,12  Previous in vitro 
studies on the inhibition of other Fe(II)/αKG-dependent enzymes by Cu(II) ion have 
only provided the IC50 values and the results have not been extrapolated to 
physiologically and pathologically relevant concentrations.6  In this work, for the first 
time we not only measured the IC50 values of Cu(II) ion on the ABH2, ABH3, and AlkB 
proteins but also tested the inhibitory effects under normal cellular and Wilson’s disease 
condition. 
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Figure 1. Repair mechanism of the AlkB family enzymes on alkyl DNA lesions and the 
inhibition of repair by Cu(II) ion.  Adduct m3C is used here as an example to show the 
enzymatic catalysis. 
 
To test the inhibitory effect of Cu(II) ion on the AlkB family enzymes, we first site-
specifically synthesized a 16mer oligonucleotide containing m3C, the major substrate 
of the AlkB family enzymes.12,13  We expressed and purified recombinant human 
ALKBH2 and ALKBH3 proteins, and the E. coli AlkB protein.14  Then, we evaluated 
the repair efficiency of the enzymes (Figure S1) and the inhibitory effect of Cu(II) ion 
under different conditions.  It has been reported that the cellular concentrations of “free” 
copper and iron ions are very limited.  Under normal cellular conditions, the 
concentration of free copper ions is 1.5 µM, which is 1.5 fold greater than free iron ions 
(1.0 µM).  For the WD patients, the level of free copper ion is increased to 24.4 µM.15  
In this work, we tested different Fe(II) ion concentrations and selected 5.0 µM to ensure 
the maximal efficiency of repair by the AlkB family enzymes (Figure S2); this 
concentration was similar to the Fe(II) ion concentrations used in other inhibition 
studies.6   The inhibitory effects of Cu(II) ion were tested from 0.0 to 100.0 µM, among 
which 7.5 µM of Cu(II) was used to mimic normal cellular condition. Though the 
cellular levels of copper ion under WD condition vary considerably from different 
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reports, all of the levels are more than 10 fold higher than the normal cellular 
concentration.1,2,15  To make this work rigorous and relevant to pathological disease 
condition, we used 75.0 µM (10 fold) of copper ion to represent the WD condition. 
For each enzymatic reaction, the m3C-containing oligonucleotides were incubated with 
the necessary cofactors for the AlkB reaction: Fe(II) ion, αKG, and ascorbic acid (see 
Experimental Section in Supporting Information) in either ss- or ds-DNA.  In a typical 
inhibition test (e.g., ALKBH2 repairing m3C), 5.0 µM of oligonucleotide substrate, and 
2.0 µM ALKBH2 enzyme were mixed with a fixed concentration of Fe(II) ion (5.0 µM) 
plus different concentrations of Cu(II) ion, and the extent of the repair reaction was 
quantified (see Experimental Section for details).  Because the AlkB family enzymes 
are able to repair DNA lesions in both ss- and ds-DNA, the repair reactions of m3C 
were carried out under both conditions.     
For the Cu(II) ion inhibition of the ALKBH2 repair reaction on m3C in ss- and ds-DNA 
(Figure 2 and Table S1), the IC50 values are 14.8 μM and 54.0 μM, respectively (Table 
1).  The IC50 values for AlkBH3 and AlkB were also measured (Table 1).  From the IC50 
tests, we found the IC50 values are higher in ds-DNA condition than ss-DNA condition 
for all three enzymes, despite the preference of AlkBH3 and AlkB to repair m3C in ss-
DNA and AlkBH2 preferring repair in ds-DNA.12  These results shows the repair under 
ds condition is less susceptible than ss condition to the inhibition from Cu(II) ion.  One 
possibility is that copper ion is harder to access to the active site of an enzyme and 
replace its iron ion due to the more crowded environment under ds-DNA binding 
condition.    
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Figure 2. IC50 measurements of Cu(II) ion on the repair of m3C by AlkBH2, AlkBH3, 
and AlkB under ss- and ds-DNA conditions.   
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Table 1. IC50 values of Cu(II) ion inhibiting the AlkB family enzymes.  The repair 
reactions of m3C were carried out under both ss- and ds-DNA conditions.  
Protein Substrate IC50 (µM) 
ALKBH2 
ss-DNA 14.8 
ds-DNA 54.0 
ALKBH3 
ss-DNA 23.8 
ds-DNA 28.4 
AlkB 
ss-DNA 10.3 
ds-DNA 29.3 
 
We then tested the inhibition of Cu(II) ion under normal physiological condition with 
the concentration at 7.5 µM.  We found that none of the three proteins were significantly 
inhibited under this concentration, with the highest inhibition at 7.0% for ALKBH3 
repairing m3C in ds-DNA. (Table S2 in SI).  These results indicated that the repair 
efficiency of the AlkB family enzymes are barely affected by Cu(II) ions under normal 
cellular conditions.  Next, we tested the inhibition of Cu(II) ions under WD condition 
with the concentration of Cu(II) ion at 75.0 µM.  We found all three enzymes were 
strongly inhibited under WD condition (inhibition from 95.2 to 100.0%, Table S2).   
In this work, we used m3C, the best substrate of AlkB, to demonstrate the AlkB family 
enzymes are strongly inhibited by high concentration of Cu(II) ion under WD condition.  
Other substrates, such as the etheno DNA lesions will be tested both in vitro and in vivo 
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in the future, which will provide a new explanation to the previously observed elevation 
of etheno adducts in Wilson’s disease.1  Considering that there are about eighty 
Fe(II)/αKG-dependent enzymes in human body,11 it is highly possible that some of those 
enzymes could be inhibited in a similar mechanism by the high concentrations of the 
copper ion under Wilson’s disease condition. 
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Figure S1. HPLC analyses of the DNA repair reactions.  Top: Starting material ss-
16mer oligonucleotide containing m3C at the lesion site.  Middle: Product ss-16mer 
oligonucleotide containing C at the “lesion site”.  Bottom: Reaction mixture of starting 
material 16mer m3C and product 16mer C. 
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Figure S2. Dose-response curve of Fe(II) ions to the AlkB repair activity on m3C.  In 
each reaction, 5.0 µM of oligonucleotide substrate, and 2.0 µM AlkB enzyme were 
mixed with different concentrations of Fe(II) ion, and the extent of the repair reaction 
was quantified. 
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Table S1. Cu(II) ion inhibition on the demethylation of m3C by the AlkB family 
enzymes in ss- and ds-DNA. The data indicate the percentiles of repair.  Each reaction 
was performed in triplicate. 
Cu(II)/µM 
ALKBH2 ALKBH3 AlkB 
ss-DNA ds-DNA ss-DNA ds-DNA ss-DNA ds-DNA 
0.0 92.6 ± 3.5 100.0 ± 0 100.0 ± 0 77.6 ± 3.1 100.0 ± 0 100.0 ± 0 
5.0 92.1 ± 2.4 97.9 ± 3.7 100.0 ± 0 75.5 ± 2.1 99.7 ± 0.1 100.0 ± 0 
7.5 88.5 ± 0.6 98.1 ± 3.2 100.0 ± 0 72.2 ± 0.5 98.3 ± 0.5 100.0 ± 0 
10.0 75.9 ± 0.5 99.0 ± 1.7 100.0 ± 0 66.4 ± 3.6 54.8 ± 3.6 100.0 ± 0 
20.0 6.5 ± 3.1 98.5 ± 1.4 74.7 ± 5.5 51.9 ± 3.1 2.6 ± 0.3 98.9 ± 1.0 
30.0 1.0 ± 0.3 90.1 ± 3.2 8.7 ± 0.8 35.5 ± 1.7 0.6 ± 0 45.3 ± 2.3 
40.0 0 ± 0 76.5 ± 2.7 1.2 ± 1.1 25.7 ± 1.7 0 ± 0 19.1 ± 1.5 
50.0 0 ± 0 54.4 ± 6 0.6 ± 1.1 16.7 ± 2.7 0 ± 0 8.4 ± 0.7 
75.0 0 ± 0 4.0 ± 1.4 0 ± 0 3.7 ± 1.2 0 ± 0 2.0 ± 0.6 
100.0 0 ± 0 0.4 ± 0.6 0 ± 0 1.7 ± 0.2 0 ± 0 0 ± 0 
 
Table S2. Cu(II) ion inhibition on the demethylation of m3C by the AlkB family 
enzymes under normal and Wilson’s Disease conditions. The data indicate the 
percentiles of inhibition.  Each reaction was performed in triplicate. 
 Cu/Fe 
ratio 
ALKBH2 ALKBH3 AlkB 
ss-DNA ds-DNA ss-DNA ds-DNA ss-DNA ds-DNA 
Normal 1.5 4.4 1.9 0.0 7.0 1.7 0.0 
Wilson's 
Disease 15.0 100.0 96.0 100.0 95.2 100.0 98.0 
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Experimental Section 
Oligonucleotide Synthesis.  The synthesis of oligonucleotides (ODNs) were described 
previously.1,2  Briefly, the 16mer DNA oligonucleotide with the sequence 5′-
GAAGACCTXGGCGTCC-3′ (X represents the 3-methylcytosine), the complementary 
23merGcp 5′-CTGGGACGCCGAGGTCTTCACTG-3′ and 23merC 5′-
CAGTGAAGACCTCGGCGTCCCAG-3′, were synthesized by MerMade-4 
oligonucleotide synthesizer. All ODNs were purified by HPLC (Thermo Fisher 
Scientific) with a DNAPac PA-100 Semi-Preparative column (Thermo Fisher 
Scientific). Solvent A of 100 mM mixture (1:1) of triethylamine-acetic acid in water 
and solvent B 100% acetonitrile were employed as mobile phases. The concentration of 
DNA was determined by NanoDrop (Thermo Fisher Scientific) with UV absorbance at 
260 nm. The ODNs were characterized by HPLC−electrospray ionization triple 
quadrupole time-of-flight mass spectrometry (AB Sciex). 
Expression and Purification of the AlkB, ALKBH2, and ALKBH3 Proteins.  The 
expression and purification of AlkB, ALKBH2, and ALKBH3 were described 
previously.1,2  Briefly, His-tagged AlkB was obtained by transforming pET-28a(+)-
AlkB into E. coli Rosetta2(DE3)pLysS (BL21(DE3)pLysS for ALKBH2 and 
ALKBH3) cells, followed by adding 1 mM isopropyl β-D-thiogalactopyranoside 
(IPTG) to induce the expression at 37 °C (37 °C for ALKBH2 and 30 °C for ALKBH3). 
The expressed proteins were purified by FPLC (GE healthcare) with an affinity 
chromatography column.  The His-tag was removed by thrombin and the final 
purification step used ion-exchange column chromatography.  
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Enzymatic Reaction.  The AlkB family demethylase activity reactions on ss- and ds-
DNA were described previously.1,2  All reactions were performed at 37°C in reaction 
buffer [5 μM Fe(NH4)2(SO4)2, 0.93 mM α-ketoglutarate, 1.86 mM ascorbic acid, and 
46.5 mM HEPES (pH 8.0) ] for 1 hour. Varying concentrations of copper (II) chloride 
(0.0, 5.0, 7.5, 10.0, 20.0, 30.0, 40.0, 50.0, 75.0, and 100.0 μM) were used for the 
inhibition tests. 16mer-m3C (ss- or ds-DNA) was pre-mixed with reaction buffer in a 
concentration of 5.0 µM. The reactions were initiated by adding 0.2 µM AlkB (2.0 µM 
for ALKBH2 and ALKBH3). The reactions were stopped by adding 10.0 mM EDTA 
followed by heating to 95 °C for 5 min. For reactions with ds-DNA, most steps were 
identical to ss-DNA reactions, except 16mer m3C containing ODN was annealed to 
23mer complimentary strand (23mer-Gcp) before reaction.  The reaction was terminated 
by adding excessive amount of 23merC ODN, which was the perfect complement to 
23mer-Gcp, with 10 mM EDTA, then heated up to 95°C and slowly cooled down to 
room temperature. Each reaction was performed in triplicate. All the results of reaction 
were analyzed by HPLC. 
HPLC conditions.  All reaction samples were quantified by DNApac PA-100 column 
(4 mm × 250 mm, Thermo Scientific) with isocratic 60% mobile B, 1.5 M ammonium 
acetate, under a constant flow rate of 1.0 mL/min. Mobile A was water. The UV 
detection wavelength was 260 nm. 
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ABSTRACT 
5-Methylcytosine (5mC) in DNA CpG islands is an important epigenetic biomarker for 
mammalian gene regulation. It is oxidized to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC), and 5-carboxylcytosine (5caC) by the ten-eleven translocation 
(TET) family enzymes, which are α-ketoglutarate (α-KG)/Fe(II)-dependent 
dioxygenases. In this work, we demonstrate that the epigenetic marker 5mC is 
biochemically modified to 5hmC, 5fC, and 5caC by another class of α-KG/Fe(II)-
dependent proteins – the DNA repair enzymes in the AlkB family, which include human 
ALKBH2, ALKBH3, and AlkB in E. coli. Theoretical calculations indicate that these 
enzymes may bind 5mC in the syn-conformation, placing the methyl group comparable 
to 3-methylcytosine, the prototypic substrate of AlkB. This is the first demonstration of 
the AlkB proteins to oxidize a methyl group attached to carbon, instead of nitrogen, on 
a DNA base. These observations suggest a broader role in epigenetics for these DNA 
repair proteins. 
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INTRODUCTION 
In mammals, methylation at the 5-position of cytosine (5-methylcytosine, 5mC, Figure 
1) is the major form of DNA modification and occurs mainly on CpG dinucleotide 
sites.(1–3) This methylation is achieved and maintained by S-adenosylmethionine-
dependent methyltransferases.(4) The reverse process termed demethylation of 5mC is 
first carried out by the ten-eleven translocation proteins (TET1, 2, and 3) through 
iterative oxidation of 5mC to 5-hydroxymethycytosine (5hmC), 5-formylcytosine (5fC) 
and 5-carboxylcytosine (5caC) (Figure 1). Subsequently, the oxidation products 5fC and 
5caC are removed and repaired back to unmethylated cytosine by thymine DNA 
glycosylase coupled with base excision repair.(1, 5–8) The 5mC modification and its 
three oxidative derivatives play important roles in epigenetic regulations and cell 
development: they function in transcriptional regulation, gene silencing and 
reprogramming.(1, 5) The misregulations of 5mC and derivatives have been associated 
with cancer and other diseases.(1, 9, 10) 
The TET family enzymes belong to the α-ketoglutarate (α-KG)/Fe(II)-dependent 
dioxygenases; they have been extensively studied in the last decade for their biological 
functions, biochemical activities and structural features.(1, 5, 6, 11) In the structures of 
the TET enzymes, the highly conserved N-terminal β-hairpin-like element for DNA-
base recognition and the C-terminal catalytic domain are also found in another family 
of α-KG/Fe(II)-dependent nucleic acid-modifying dioxygenases, the AlkB family 
proteins.(5, 12, 13) In this work, we show that the epigenetic modulator 5mC is modified 
in vitro to 5hmC, 5fC, and 5caC by the DNA repair enzymes in the AlkB family, 
including human ALKBH2, ALKBH3, and its Escherichia coli (E. coli) homolog AlkB 
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(Figure 1). The results suggest that these DNA repair enzymes may play a wider role in 
epigenetic modulation. 
 
Figure 1. Reaction pathway of the AlkB family DNA repair enzymes modifying 5mC 
and 3mC. 
 
Different homologs of the E. coli AlkB protein exist in prokaryotic and eukaryotic 
species; nine homologs exist in human cells (ALKBH1-8 and FTO).(12, 14) Among the 
nine homologs, ALKBH2 and ALKBH3 are DNA repair enzymes that protect the 
informational integrity of the genome.(5, 14–18) They use an α-KG/Fe(II)-dependent 
mechanism to oxidize aberrant alkyl groups, ultimately restoring the undamaged DNA 
bases.(14, 17, 18) The reported substrate scope of AlkB, ALKBH2 and ALKBH3 
includes 3-methylcytosine (3mC, Figure 1), 1-methyladenine (1mA), 3-methylthymine 
(3mT) and 1-methylguanine (1mG), as well as other nitrogen-attached methyl lesions 
occurring at the Watson-Crick base pairing interface of DNA bases.(15, 16, 18–20) 
Key structural information about the AlkB family enzymes has been obtained from 
crystal structures of AlkB and ALKBH2 bound to lesion-containing DNA, which reveal 
that their active sites share several characteristics. Specifically, the AlkB (ALKBH2 in 
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brackets) complex contains a metal center Fe(II) in the wild-type enzymes) coordinated 
to H131 (H171), H187 (H236), D133 (D173), α-KG, and molecular oxygen.(13, 21) 
Repair of 3mC or 1mA has been proposed to be further enhanced by interactions 
between D135 of AlkB (E175 of ALKBH2) and the exocyclic amino groups of the 
lesion.(22) Interestingly, all crystal structures of the AlkB enzymes indicate the lesions 
are bound in the anti glycosidic bond conformation (e.g., for 3mC: χ; ∠(O4′C1′N1C2) 
=  180° ± 90°, Figure S18a.) 
Although both 5mC and 3mC carry a methyl modification, the methyl groups are on 
the opposite sides of the pyrimidine ring. It is reasonable to predict that members of the 
AlkB enzyme family may be able to oxidize 5mC if the methyl group can be positioned 
near the catalytic center. The in vitro experimental results demonstrated here reveal that 
the AlkB enzymes can not only repair DNA lesions, such as 3mC, but also modify the 
epigenetic biomarker 5mC and generate its oxidative derivatives. Our theoretical 
calculations suggest that AlkB enzymes bind 5mC in the syn glycosidic conformation 
(χ = 0° ± 90°, Figure S18b) to align the 5-methyl moiety for oxidation, which is similar 
to how the TET family enzymes bind 5mC. This paper is the first work to demonstrate 
the ability of the AlkB family enzymes to oxidize a methyl group that is attached to 
carbon, instead of nitrogen, on a DNA base. 
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MATERIAL AND METHODS 
Synthesis of oligonucleotides containing 5mC and other modifications.  All 
oligonucleotides used in this study were synthesized by solid-phase synthesis.(23–26)  
The 5mC and other phosphoramidites was purchased from Glen Research.  Synthetic 
oligonucleotides were purified by reverse-phase HPLC and identified by electrospray 
ionization mass spectrometry (ESI-MS). 
Protein expression and purification.  The expression and purification of ALKBH2, 
ALKBH3 and AlkB proteins were described by previous published papers.(23, 24)  
ALKBH2 and ALKBH3 in storage buffer containing 50 mM N-
[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid (TAPS), 300 mM NaCl, 10% 
glycerol, and 1 mM 2-mercaptoethanol, pH 8.0, AlkB in similar storage buffer (10 mM 
Tris, 100 mM NaCl, 1 mM 2-mercaptoethanol, 10% glycerol, pH 8.0), were all stored 
at -80 °C. 
Enzymatic reaction.  The reactions were performed based on previous published 
procedures.(23, 24)  A 16mer oligonucleotide containing one 5mC with sequence of 5’-
GAAGACCT-5mC-GGCGTCC-3’ was used as the substrate.  One hundred pmol 16mer 
5mC was mixed into reaction buffer (5 μM Fe(NH4)2(SO4)2, 0.93 mM α-ketoglutarate, 
1.86 mM ascorbic acid, and 46.5 mM TAPS, pH 7.0) in a total volume of 16 µL.  The 
reactions were started by adding proteins (170 pmol AlkB, 140 pmol ALKBH2 or 128 
pmol ALKBH3), and incubated at 37 °C for 1 hour.  EDTA was employed to quench 
the reactions and the reaction mixture was immediately heated up to 80 °C for 5min.  A 
16/23mer duplex DNA was preannealed as the substrate for dsDNA reaction.(24, 25)  
The 23mer oligonucleotide is complementary to the 16mer sequence plus 7 nucleotides 
 92 
 
longer with the sequence of 5’-CTGGGACGCCGAGGTCTTCACTG-3’.  The rest 
steps of dsDNA reaction were the same as ssDNA reaction described above.  All 
reactions were carried out in triplicates.  
Oligonucleotide digestion.  The procedures of oligonucleotide digestion to 
deoxyribonucleoside were adopted from published procedure.(27)  A digestion mixture 
was premade by adding 250 Units Benzonase (Sigma-Aldrich, MO), 300 mUnits 
phosphodiesterase I (Sigma-Aldrich, MO) and 200 Units alkaline phosphatase (Sigma-
Aldrich, MO) to 5 mL Tris-HCl buffer (20 mM, pH 7.9) containing 100 mM NaCl and 
20 mM MgCl2. Reaction of oligonucleotide containing 5mC with AlkB was quenched 
by heating up to 80°C for 5 min, then digested by adding 50 µL digestion mixture and 
incubating at 37°C for 6 hours.  The nucleoside products were analyzed by HPLC-MS.  
Samples were chromatographed on a Luna Omega Polar C18 column (150 X 4.6 mm, 
5µm, 100Å, Phenomenex, CA) eluted at 1 mL/min with an acetonitrile gradient (1%-
15%).  ESI triple quadrupole time of flight mass spectrometry was conducted to detect 
nucleoside signals in the negative ion mode.  Standard deoxyribonucleosides (including 
dA, dT, dC, dG, 5mdC, 5hmdC, 5fdC and 5cadC) were purchased from Berry & 
Associates (MI). 
Protein digestion.  The trypsin digestion of wide type AlkB and its variants were set 
up according to Trypsin-ultraTM kit (New England Biolabs, MA).  Ten µg of AlkB 
proteins were mixed with 250 ng trypsin in trypsin-ultra buffer, incubating at 37 °C 
overnight.  The protein fragments were analyzed by HPLC-MS.(24, 26)  Standard 
protein fragments (including LFYHGIQPLK and LSLHQDK sequences) were 
purchased from New England Peptide (MA). 
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Preparing catalytically inactive variants of AlkB.  The AlkB H131A, D133A, and 
H187A variants were generated by QuikChange Mutagenesis (Agilent), using pET24a-
AlkBΔN11 as the PCR template and primer pairs encoding the desired mutations.  All 
three variants were purified essentially as described.(28)  Briefly, One Shot BL21 Star 
(DE3)pLysS E. coli cells (Invitrogen) transformed with an AlkB variant construct were 
grown at 37 °C until OD600 had reached ~0.4, at which point the temperature was 
lowered to 30 °C and protein production was induced by addition of 1 mM IPTG.  Cells 
were harvested after 4 h and stored at −80 °C until use.  For purification, cell pellets 
were resuspended in lysis buffer (10 mM Tris, pH 7.3, 300 mM NaCl, 2 mM CaCl2, 10 
mM MgCl2, 5% (v/v) glycerol, 1 mM 2-mercaptoethanol) and lysed by sonication.  
After clarification by centrifugation, the lysate was loaded onto a Ni-NTA column 
(Qiagen), the column was washed twice with lysis buffer supplemented with 10 mM 
and 20 mM imidazole, and bound protein was eluted with lysis buffer supplemented 
with 70 mM and 250 mM imidazole.  Elution fractions containing AlkB, as assessed by 
SDS-PAGE, were combined and dialyzed for 16 h against 50 mM 2-[[1,3-dihydroxy-2-
(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid (TES), pH 7.1 with or without 
20 mM NaCl, and loaded onto a 5 mL HiTrap SP cation exchange column (GE 
Healthcare).  Bound AlkB was eluted with a linear gradient of 0.02 – 1 M NaCl over 12 
column volumes (60 mL).  Fractions containing pure AlkB were pooled and purity was 
established by SDS-PAGE. 
Computational methodology.  X-ray crystal structures of AlkB (PDB ID: 3O1S)(22) 
and ALKBH2 (PDB ID: 3RZJ)(21) bound to lesion-containing DNA were chosen as 
initial structures.  The 3O1S crystal structure contains AlkB bound to an oxidized 3mC 
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intermediate-containing DNA, Fe(II) ion, and succinate.  The oxidized intermediate was 
reverted to 3mC, and a water molecule bound to Fe(II) was modelled as an oxo ligand 
to generate the Fe(IV)–oxo complex.  To generate the active Fe(IV)–oxo ALKBH2 
complex, the cofactors (Fe(IV), succinate, and oxo ligand) and metal-binding amino 
acids (H131, D133, and H187) of the AlkB complex were super imposed onto the 
cofactors (Mn(II) and α-KG) and metal-binding amino acids (H171, D173, and H236) 
of the ALKBH2 complex.  Hydrogen atoms were assigned using the tLEaP AMBER 
utility.(29)  Protonation states of ionizable amino acids were initially assigned using 
H++(30) and adjusted using chemical intuition.  For AlkB, H66, H97, H172, and H197 
were assigned epsilon protonation, while H72, H131, and H187 were assigned delta 
protonation.  For ALKBH2, H55, H59, H106, H144, and H228 were assigned epsilon 
protonation, H199 and H220 were assigned delta protonation, and H167 was modelled 
as cationic.  All crosslinks induced to facilitate crystallization between DNA and protein 
were removed for both complexes.  The G169C, C67S, C165S, and C192S mutations 
to ALKBH2 were reverted to generate the wild-type enzyme, and the overhanging DNA 
ends (residues 259, 260, and 284) were truncated.  To generate the AlkB–5mC or 
ALKBH2–5mC complexes, the anti and syn conformations of the 5mC nucleotide were 
overlaid onto the 3mC substrate in the ALKBH2- or AlkB-DNA complex using 
chemical intuition to minimize steric clashes between the bound substrate and active 
site amino acids. 
Each complex was modelled using the AMBER parm14SB force field.  Parameters 
assigned to the nonstandard 5mC and 3mC nucleotides were supplemented with GAFF 
parameters, and Restrained Electrostatic Potential (RESP) charges.  For Fe(IV) and the 
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iron-ligating residues, the Metal Center Parameter Builder(31) was used to assign RESP 
charges, and bonding, angle, dihedral and non-bonding parameters based on 
B3LYP/LANL2DZ (Fe(IV)) and B3LYP/6-31G(d,p) (H, C, N, and O) optimized 
structures (Gaussian 09 revision D.01)(32) of the iron-binding site using the Seminario 
method.(33)  The complexes were neutralized with Na+ counter ions, and solvated in a 
water box such that at least 10.0 Å of water exists between the DNA–protein complex 
and water box boundary.  
All minimization, heating, equilibration, and production steps were performed with the 
GPU-accelerated PMEMD module available in AMBER 14 or AMBER 16.(34–36)  For 
each step, the particle mesh Ewald method was used to employ a 10.0 Å electrostatic 
cutoff.  To minimize each system, 1000 cycles of steepest descent (SD) and subsequent 
1000 cycles of conjugate gradient (CG) minimization were first applied to the solvent 
and Na+ counter ions, followed by the complex hydrogen atoms, and finally the complex 
heavy/hydrogen atoms.  For the final minimization step, the entire system was subjected 
to 1000 cycles of SD minimization followed by 2000 cycles of CG minimization.  
Subsequently, each system was heated to 310 K over 120 ps with a 25.0 kcal mol–1 Å–2 
restraint placed on the solute using the Langevin thermostat with a time step of 1 fs 
under NVT conditions.  The 25.0 kcal mol–1 Å–2 restraint was reduced to 0.0 kcal mol–
1 Å–2 over 100 ps under constant temperature and pressure conditions (Berendsen 
barostat) using a 2 fs time step and SHAKE to constrain bonds involving hydrogen, 
which was followed by 1 ns of unrestrained equilibration.  Several pre-production 
simulations were performed for each system to ensure adequate sampling and 
accommodation of each substrate within the active site of ALKBH2 or AlkB.  
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Representative structures (clustering methodology below) were chosen from these pre-
production simulations to initiate the final 100 ns production simulations.  Coordinates 
were saved from each simulation every 5 ps and analyzed over the same interval. 
The CPPTRAJ(37) module was utilized for analysis of each trajectory.  The occupancy 
of hydrogen bonds is reported for the duration of the simulation that the heavy atom 
distance is < 3.4 Å and the hydrogen-bonding angle is > 120°.  To examine the 
placement of water within the active site, a three dimensional 20 Å3 grid centered on 
the bound substrate was generated.  Dark red spheres are shown on representative 
structures and reflect an oxygen atom of a water molecule located in a 0.25 Å3 grid 
space for at least 40% of the simulation.  The pre-production and production trajectories 
were clustered according to the positions of key active site residues (bound substrate, 
W69, H131, D135 and E136 for AlkB, and bound substrate, F124, H171, D174 and 
E175 for ALKBH2).  A hierarchical agglomerative clustering methodology was used to 
obtain a 3.0 Å minimum cutoff between clusters or four clusters were obtained.  While 
the representative structures are static snapshots, we report key structural parameters 
over the entire trajectory to ensure that conclusions are representative of each simulation 
trajectory. All distances are reported in Å and all angles are reported in degrees. 
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RESULTS AND DISCUSSION 
A 16mer DNA oligonucleotide (5’-GAAGACCTXGGCGTCC-3’, X = 5mC) 
containing 5mC in a CpG dinucleotide context was prepared through solid phase DNA 
synthesis with the phosphoramidite of 5mC.(23–26) High resolution electrospray 
ionization time-of-flight (ESI-TOF) MS analysis of the oligonucleotide exhibited an 
m/z of 1625.281 at its -3 charge state, which is in good agreement with the theoretical 
m/z 1625.281 expected of the product oligonucleotide (Figure 2a and Table S1). In the 
same -3 charge envelope, we also observed the ions of 5mC + Na+ (1632.608) and 5mC 
+ K+ (1637.928). The observed m/z values of these species are consistent with the 
corresponding calculated m/z values (Table S1). 
Previously, our lab has purified the three AlkB family enzymes mentioned above and 
tested their repair efficiency for 3mC, 1mA, 3mT, and 1mG in both ss- and ds-DNA.(23, 
24) Similar procedures were adopted for the modification reactions of 5mC. The 
reaction conditions and the oligonucleotide-enzyme ratios are similar to those observed 
in the conversion of 5mC to its oxidative derivatives by the TET proteins reported in 
the literature.(6–8) For each enzyme, experiments were conducted in triplicate both in 
the presence and absence of the enzyme with all necessary cofactors at 37°C under both 
ds- and ss-DNA conditions, and the reaction products were analyzed by high resolution 
MS to ensure the differentiation of reaction products that have very similar m/z 
values.(24) 
First, we tried to identify the new oxidative products that appeared after the enzymatic 
reactions. The three oxidative products, 5hmC, 5fC, and 5caC, all formed in the 
reactions with all three enzymes, but every enzyme had a preference to generate a 
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certain oxidative derivative. Below we use typical examples to demonstrate the 
formation of a certain product. The MS results of ALKBH2 oxidizing 5mC in ds-DNA 
(Figure 2b) showed a new oligonucleotide species that has an m/z for the monoisotopic 
peak at 1630.615 at -3 charge state, which corresponds well to the theoretical m/z value 
of the 16mer oligonucleotide containing 5hmC (1630.612 calculated, Table S1). In the 
reaction of 5mC with ALKBH3 in ss-DNA, another oligonucleotide envelope appeared 
at m/z 1629.951 (Figure 2c), which agrees with the 5fC base in the 16mer 
oligonucleotide (1629.940 calculated). For the oxidation of 5mC by the AlkB protein in 
ss-DNA, we observed the peak envelopes of 5hmC (1630.603), 5fC (1629.933) together 
with a new species with an m/z value of 1642.604, which is close to the 16mer 
oligonucleotide containing the sodium salt of 5caC (1642.600 calculated, Figure 2d and 
Table S1). Other oligonucleotide species containing metal ions, such as Na+ and K+, 
were also observed. The complete assignments of the major species generated from MS 
analyses are summarized in Figure S1 and Table S1. 
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Figure 2. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides 
containing 5mC and oxidized products. The observed m/z values represent the 
oligonucleotides under their -3 charge state. a) 5mC; b) 5mC (in ds-DNA) + ALKBH2; 
c) 5mC (in ss-DNA) + ALKBH3; and d) 5mC (in ss-DNA) + AlkB. 
 
The product oligonucleotides were digested into single nucleosides, analyzed by LC-
MS, and compared with standard nucleosides to confirm the oxidative products 
generated from enzymatic reactions are indeed 5hmC, 5fC, and 5caC (see the Product 
oligonucleotides analyses section in SI, Figure S2 to S10). Also, to make sure the 
oxidations were carried out by AlkB and its homologs, we generated the catalytically 
inactive protein variants of AlkB: H131A, D133A, and H187A (Figure S11). The three 
substituted amino acids in AlkB are the key residues that coordinate the Fe(II) ion.(13, 
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38) The sequences of wild type and variant proteins were confirmed by trypsin digestion 
with MS analyses (Figure S11 and Table S2). None of the AlkB variants showed any 
detectable oxidative product when reacted with 5mC (Figure S12); these observations 
suggest that the oxidative modifications were carried out by AlkB and not by a 
contaminating enzyme. 
For the oxidation of 5mC, the formation of products 5hmC, 5fC, and 5caC had different 
distribution patterns for the three enzymes; and the three enzymes had different 
preferences for oxidation in ss- or ds-DNA reactions (Figure 3 and the Product 
distribution for the oxidation of 5mC section in SI). The overall activities of the three 
AlkB proteins on oxidizing 5mC are similar to the proficiencies of the TET enzymes on 
modifying 5mC reported in the literature(6–8) and are generally consistent with 
theoretical calculations that report higher barriers for each successive oxidation steps by 
TET2.(39)  The conversion of 5mC to the corresponding oxidative intermediates by the 
AlkB proteins were comparable to their repair of other known substrates (Modifications 
on different alkyl substrates by the AlkB enzymes section in SI). In all of the enzymatic 
reactions, we only observed the oxidation of 5mC, but not the thymine DNA base, which 
naturally has a 5-methyl group. The same finding was reported for the TET family 
enzymes.(8)  
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Figure 3. Product distribution and strand preference (in univariate scatterplot) for the 
oxidation of 5mC by the AlkB family enzymes. Reaction products (5hmC, 5fC and 5caC) 
generated from the reactions of 5mC with the AlkB family enzymes in a) ds-DNA and 
b) ss-DNA. c) Total product percentage from reactions of the AlkB family enzymes 
oxidizing 5mC in ds- and ss-DNA. 
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To probe the molecular basis by which the AlkB enzymes are able to oxidize 5mC, we 
performed molecular dynamics (MD) simulations to examine how 5mC is 
accommodated in the active sites of ALKBH2 and AlkB (Figure 4). We found that the 
5-methyl of anti-5mC in our model is far from the Fe(IV)–oxo moiety (~5.3 Å for 
ALKBH2 in Figure 4a and ~7.9 Å for AlkB in Figure 4d; also in Figures S13-S14, and 
Tables S3-S6). In contrast, the distances between the Fe(IV)–oxo moiety and the 5-
methyl group in the models with syn-5mC bound to ALKBH2 or AlkB are much shorter 
(~3.8 Å for ALKBH2 in Figure 4b and ~3.6 Å for AlkB in Figure 4e) and similar to the 
distances in the structures of ALKBH2 or AlkB bound to their prototypic substrate 3mC 
in the anti-conformation (~3.3 Å for ALKBH2 in Figure 4c and ~3.3 Å for AlkB in 
Figure 4f.; See also the Simulations of ALKBH2 and AlkB bound to 3mC, 5hmC, and 
5fC section in SI). With syn-5mC bound to ALKBH2 and AlkB, hydrogen bonds appear 
possible between the N4 amino group of 5mC and active site residues. Specifically, syn-
5mC interacts with Asp and Glu residues (D174/E175 for ALKBH2, and D135/E136 
for AlkB) through water (Tables S3-S4 and Figures S13-S14), as well as the Y122 
hydroxy group in ALKBH2 (Table S3). These interactions likely facilitate oxidative 
catalysis by positioning the C5 methyl group near the Fe(IV)–oxo moiety (~3.6 – 3.8 Å; 
Tables S5-S6). 
Interestingly, a crystal structure of TET2 co-crystallized with 5mC-containing DNA 
reveals syn-5mC in the active site,(40) and the reported χ torsion angle is consistent with 
that predicted for syn-5mC in ALKBH2/AlkB (Figure S15 and Tables S5-S6). Based 
on our combined experimental and theoretical data, we propose that the AlkB family 
enzymes are able to oxidize 5mC bound only in the syn-conformation. 
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Figure 4. Representative molecular dynamics structures of the ALKBH2 (a-c) or AlkB 
(d-f) complex bound to anti-5mC (a,d), syn-5mC (b,e), or anti-3mC (c,f). The distance 
between the oxo-moiety and methyl groups is highlighted with dashed lines. 
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To provide insight into the variable activities of ALKBH2 and AlkB for subsequent 
nucleobase oxidation (Figure 3), MD simulations were performed on syn-5hmC and 5fC 
bound in the active sites. For 5hmC, the C5 substituent is further from the Fe(IV)–oxo 
moiety for ALKBH2 (~4.5 Å, Figure S16 and Tables S5) compared to AlkB (3.4 Å, 
Figure S17 and Tables S6), which is consistent with the relative low abundance of the 
5fC product for ALKBH2 (Figures 3, S19 to S21 and Tables S3 to S6). For 5fC, 
increased flexibility of the bound nucleobase may permit enhanced catalysis and 
generate more 5caC for ALKBH2 comparing to AlkB (Figures 3a, 3b, and S22). In 
addition to the insights provided by the MD simulations (see SI for detailed discussions 
of these calculations), several other factors could influence the product distributions 
including DNA binding, oxidative reactivity and different base flipping mechanisms 
used by each enzyme. 
In this paper, we demonstrated the in vitro oxidative modification of 5mC to 5hmC, 5fC, 
and 5caC by the three AlkB DNA repair enzymes. Thus, the AlkB proteins are not only 
able to repair DNA adducts, such as 3mC and 3mT, but also can edit the epigenetic 
modification 5mC and generate the corresponding oxidative derivatives. These 
observations suggest a possible connection between DNA repair and epigenetic gene 
modulation. Future investigation includes analyzing the kinetic parameters of the three 
AlkB enzymes acting on 5mC, confirming the oxidation of 5mC by the AlkB enzymes 
in cell, and probing whether other α-KG/Fe(II)-dependent dioxygenases can oxidize 
5mC. 
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TABLE AND FIGURES LEGENDS 
Figure 1. Reaction pathway of the AlkB family DNA repair enzymes modifying 5mC 
and 3mC. 
Figure 2. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides 
containing 5mC and oxidized products. The observed m/z values represent the 
oligonucleotides under their -3 charge state. a) 5mC; b) 5mC (in ds-DNA) + ALKBH2; 
c) 5mC (in ss-DNA) + ALKBH3; and d) 5mC (in ss-DNA) + AlkB. 
Figure 3. Product distribution and strand preference (in univariate scatterplot) for the 
oxidation of 5mC by the AlkB family enzymes. Reaction products (5hmC, 5fC and 5caC) 
generated from the reactions of 5mC with the AlkB family enzymes in a) ds-DNA and 
b) ss-DNA. c) Total product percentage from reactions of the AlkB family enzymes 
oxidizing 5mC in ds- and ss-DNA. 
Figure 4. Representative molecular dynamics structures of the ALKBH2 (a-c) or AlkB 
(d-f) complex bound to anti-5mC (a,d), syn-5mC (b,e), or anti-3mC (c,f). The distance 
between the oxo-moiety and methyl groups is highlighted with dashed lines. 
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Product oligonucleotides analyses 
It was important to assure that the observed new oligonucleotide species indeed contain 
the proposed oxidative products.  The product oligonucleotides were digested with 
benzonase into single nucleosides, which were analyzed by LC-MS and compared with 
standard nucleosides for retention time and molecular weight.  In the digestion of the 
product generated from the AlkB reaction, a nucleoside was eluted out at 7.3 min in 
HPLC (Figure S2) and had an observed m/z 240.2386 in the negative mode of MS 
analysis (theoretical m/z 240.2392, Figure S4); these data agree well with the analysis 
of the standard sample of 5mC nucleoside (7.3 min in HPLC and 240.2385 in m/z, 
Figure S3).  Another nucleoside from digestion had a retention time at 4.9 min in HPLC 
(Figure S2) and had an m/z 256.2387 in the MS analysis (Figure S6); these data are 
comparable to the standard sample of 5hmC nucleoside (5.0 min in HPLC and 256.2409 
in m/z, theoretical m/z 256.2382, Figures S2 and S5).  Similarly, nucleosides 5fC and 
5caC were also discovered in the mixture of the digested reaction product and their 
identities were confirmed by comparing to standard nucleosides (Figures S2, S7 to S10).  
These observations support that the oxidative products generated from enzymatic 
reactions are indeed 5hmC, 5fC, and 5caC. 
 
Product distribution for the oxidation of 5mC 
For the oxidation of 5mC, the formation of products 5hmC, 5fC, and 5caC had different 
distribution patterns for the three enzymes; and the three enzymes had different 
preferences of oxidation in ss- or ds-DNA reactions (Figure 3).  The relative amount of 
each product in the final reaction mixture was quantified according to the abundance of 
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its corresponding ion at -3 charge state in the MS analysis.  The product oligonucleotides 
containing 5hmC was the dominant species for the reactions of ALKBH2 and 3 in both 
ds- and ss-DNA (Figures 3a and 3b).  For example, 5hmC represents 78.7% of the total 
amount of the three oxidative products in the reaction of ALKBH2 with 5mC in ds-
DNA; 5fC and 5caC are quantified as 10.9% and 10.4% correspondingly (Figure 3a).  
For the oxidation of 5mC by AlkB, 5hmC is the major species (51.2%) in ds-DNA 
reaction; however, 5fC is the most abundant species (65.3%) in ss-DNA reaction 
(Figures 3a and 3b).  We were also able to quantify the yield of the oxidative products 
by comparing them to the total oligonucleotide species.  The ratios of the oxidative 
products show ALKBH2 prefers to oxidize 5mC in ds-DNA (8.7%) over in ss-DNA 
(5.5%), and ALKBH3 prefers to modify 5mC in ss-DNA (22.1%) over in ds-DNA 
(4.2%) (Figure 3c).  These results support the strand preference in repair reactions of 
ALKBH2 (preferring ds-DNA) and ALKBH3 (preferring ss-DNA) reported in the 
literature.(1)  For AlkB, the enzyme oxidized 5mC in ss-DNA (23.5%) more efficiently 
than in ds-DNA (13.3%) (Figure 3c); these results are similar to the preference of AlkB 
repairing 3mC in ss-DNA.(2)  
 
Modifications on different alkyl substrates by the AlkB enzymes 
We compared the conversion efficiency of 5mC by the three AlkB family enzymes to 
other known methyl substrates of the AlkB proteins. Those substrates include 3mC, 
1mA, 3mT, and 1mG; and all of them have been demonstrated to be repaired by AlkB 
both in vitro and in vivo.(1, 3) The results show the conversion of 5mC to the 
corresponding oxidative products are comparable to the demethylation of 3mT and 
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1mG; and the reactions of these three methyl modifications are slower than 3mC and 
1mA (Figure S23 and Table S7). For example, T1/2 of the reactions for 5mC (16.9 min) 
is slightly shorter than 3mT (17.4 min) but longer than 1mG (1.7 min) in the AlkB 
reactions. For the ALKBH2 reactions, T1/2 for 5mC are comparable to 3mT and 1mG 
(all between 16.4 to 18.7 min). For the ALKBH3 protein, 5mC is oxidized faster than 
3mT and 1mG with about 5 minutes shorter in T1/2 than the other two (Figure S23 and 
Table S7). Those biochemical results may indicate similar modification could happen 
in cell: the modification of 5mC is comparable to the weaker AlkB substrates 3mT and 
1mG but less efficiently than the stronger substrates 3mC and 1mA.(3)  
 
Simulations of AlkBH2 and AlkB bound to 3mC, 5mC, 5hmC, and 5fC 
To validate that the simulated structures of the ALKBH2 or AlkB complexes are 
consistent with the observed catalytic activity, we examined the active site 
conformations adopted upon binding of both enzymes to anti-3mC-, syn-5mC-, syn-
5hmC-, or syn-5fC-containing DNA.  Similar DNA–protein interactions form when 
3mC and 5mC are bound.  Specifically, the 3mC N4 amino group forms direct hydrogen 
bonds with the D174 or E175 sidechains when bound to ALKBH2 (Figure S16b and 
Table S3), and direct or water-mediated hydrogen bonds with D135 and E136 when 
bound to AlkB (Table S4 and Figure S17).  As a result, the N3 methyl group of 3mC 
occupies an equivalent active site position as the C5 methyl group of 5mC for both 
enzymes (Figures S16b and S17b), with a distance between the Fe(IV)–oxo and the 
3mC methyl moiety of ~ 3.3 Å for both enzymes (Tables S5-S6), and the syn-5mC 
moiety of ~3.6 Å for AlkB and 3.8 Å for ALKBH2. Thus, the simulation data is 
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consistent with the proposal that the AlkB family of enzymes is able to oxidize 5mC in 
the syn orientation.  
Similar to ALKBH2 or AlkB bound to 5mC, syn-5hmC is stabilized by direct or water-
mediated hydrogen bonds between the N4 amino group of the nucleobase and the 
carboxylate moieties of D174 and E175 (D135 and E136 in AlkB; Tables S3-S4 and 
Figure S20). For 5hmC bound by ALKBH2 or AlkB, hydrogen bonds are formed 
between the C5 substituent hydroxy group and the Fe(IV)-oxo moiety (occupancy = 
34% for ALKBH2 and 52% for AlkB; Tables S3-S4 and Figure S21). In ALKBH2, an 
additional hydrogen bond is formed between the C5 substituent hydroxy group and 
D173 (59%, Table S3), which results in one orientation of the C5 substituent throughout 
the simulation (Figure S21a). In contrast, the C5 substituent hydroxy group does not 
interact with D133 in AlkB, which results in two conformations of 5hmC within the 
active site (Figure S21b-d). More importantly, the C5 substituent is at an optimum 
distance from the Fe(IV)-oxo moiety in AlkB (~3.4 Å), which matches the prototypic 
substrate (3mC; ~3.3 Å), while the equivalent distance is longer in the ALKBH2–5hmC 
complex (~4.5 Å; Tables S5-S6 and Figure 3), which would impede catalysis. This helps 
explain the observed higher abundance of 5fC for AlkB compared to ALKBH2 
catalyzed oxidation on 5hmC, although several other factors could also be significant 
such as DNA binding and unique base flipping mechanism for each enzyme.  
As discussed for 5mC and 5hmC, the syn-conformation of 5fC is stabilized by 
hydrogen bonds between the N4 amino group of the nucleobase and carboxylate 
sidechains of active site residues (Tables S3-S4 and Figure S20). When bound to either 
ALKBH2 or AlkB, 5fC is planar due to an intramolecular hydrogen bond between the 
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N4 amino group and the carbonyl of the C5 substituent. A hydrogen bond also forms 
between the carbonyl of the C5 substituent and an active site arginine, which is notably 
more persistent for AlkB (R210, occupancy = 100.0%) than ALKBH2 (R254, 
occupancy = 29.2%, Tables S3-S4 and Figure S20). As a result, the distance between 
the hydrogen atom of the C5 substituent and the Fe(IV)-oxo group is longer for AlkB 
(~3.8 Å) compared to ALKBH2 (3.3 Å; Tables S5-S6 and Figure S22). Although the 
difference in distance for 5fC bound by ALKBH2 and AlkB is not as significant as 
observed for 5hmC, QM/MM studies on TET2-catalyzed oxidation of 5mC, 5hmC, and 
5fC reveal that the initial hydrogen atom abstraction step is rate limiting, with the barrier 
increasing as 5mC < 5hmC < 5fC.(4) This suggests that the position of the substituent 
relative to the Fe(IV)-oxo group is even more crucial in the case of 5fC. Thus, our 
predicted structures correlate with the lower abundance of 5caC relative to 5fC for AlkB 
compared to ALKBH2 (Figure 3). Nevertheless, as discussed for 5hmC, nucleotide 
recognition and the base flipping mechanism could also play different roles in oxidative 
conversion of 5fC to 5caC. 
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Figure S1. ESI-TOF analyses of standard oligonucleotide containing 5mC and reaction 
mixtures. The observed m/z values represent the oligonucleotides under their -3 charge 
state. The theoretical m/z values of the corresponding species are listed in Table S1. 
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Figure S2. HPLC analyses of deoxyribonucleoside standards and benzonase digested 
product oligonucleotides.  
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Figure S3. MS analysis of standard 5mC deoxyribonucleoside under negative ion mode. 
The theoretical m/z value of the corresponding species is listed next to the observed 
peak. 
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Figure S4. MS analysis of digested oligonucleotide containing 5mC 
deoxyribonucleoside under negative ion mode. The theoretical m/z value of the 
corresponding species is listed next to the observed peak. 
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Figure S5. MS analysis of standard 5hmC deoxyribonucleoside under negative ion 
mode. The theoretical m/z value of the corresponding species is listed next to the 
observed peak. 
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Figure S6. MS analysis of digested oligonucleotide containing 5hmC 
deoxyribonucleoside under negative ion mode. The theoretical m/z value of the 
corresponding species is listed next to the observed peak. 
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Figure S7. MS analysis of standard 5fC deoxyribonucleoside under negative ion mode. 
The theoretical m/z value of the corresponding species is listed next to the observed 
peak. 
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Figure S8. MS analysis of digested oligonucleotide containing 5fC 
deoxyribonucleoside under negative ion mode. The theoretical m/z value of the 
corresponding species is listed next to the observed peak. 
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Figure S9. MS analysis of standard 5caC deoxyribonucleoside under negative ion mode. 
The theoretical m/z value of the corresponding species is listed next to the observed 
peak. 
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Figure S10. MS analysis of digested oligonucleotide containing 5caC 
deoxyribonucleoside under negative ion mode. The theoretical m/z value of the 
corresponding species is listed next to the observed peak. 
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Figure S11. MS analyses of trypsin digested proteins including the wild type and variant 
AlkB enzymes. 
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Figure S12. ESI-TOF analyses of standard oligonucleotide containing 5mC and 
reaction mixtures with wild type and variant proteins. The observed m/z values 
represent the oligonucleotides under their -3 charge state. The theoretical m/z values of 
the corresponding species are listed in Table S1. 
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Figure S13. Distribution of active site water (red spheres) during MD simulations of 
ALKBH2 bound to a) anti-5mC or b) syn-5mC. c) ALKBH2 bound to syn-5mC 
highlighting key hydrogen-bonding interactions. d) Overlay of MD representative 
structures of ALKBH2 bound to anti- (blue) or syn- (gray) 5mC. 
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Figure S14. Distribution of active site water (red spheres) during MD simulations of 
AlkB bound to a) anti-5mC or b) syn-5mC. c) AlkB bound to syn-5mC highlighting key 
water mediated hydrogen-bonding interactions.  d) Overlay of MD representative 
structures of AlkB bound to anti- (cyan) or syn- (blue) 5mC.  
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Figure S15. Overlay of the 5mC nucleotide isolated from MD representative structures 
of AlkB–5mC (blue) and ALKBH2–5mC (gray) complexes onto a crystal structure of 
TET2 bound to 5mC-containing DNA, Fe(II), and α-KG (teal; PDB ID: 4NM6),(5) 
highlighting the similarity in the 5mC glycosidic bond conformation (χ). 
 138 
 
 
Figure S16. Distribution of active site water during MD simulations of ALKBH2 bound 
to anti-3mC and overlay of MD representative structures of ALKBH2 bound to syn-
5mC and anti-3mC.  a) Distribution of active site water (red spheres) during MD 
simulations of ALKBH2 bound to anti-3mC. b) ALKBH2 bound to anti-3mC, 
highlighting key hydrogen-bonding interactions. c) Overlay of MD representative 
structures of ALKBH2 bound to syn-5mC (gray) and anti-3mC (blue). 
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Figure S17. Distribution of active site water during MD simulations of AlkB bound to 
anti-3mC and overlay of MD representative structures of AlkB bound to syn-5mC and 
anti-3mC.  a) Distribution of active site water (red spheres) during MD simulations of 
AlkB bound to anti-3mC. b) AlkB bound to anti-3mC, highlighting key water mediated 
hydrogen-bonding interactions. c) Overlay of MD representative structures of AlkB 
bound to syn-5mC (blue) and anti-3mC (cyan). 
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Figure S18. Structures and chemical numbering of a) 3mC and b) 5mC. The glycosidic 
bond orientation is defined by dihedral angle χ (blue, ∠O4′C1′N1C2) as either anti (left, 
180 ± 90°) or syn (right, 0 ± 90°). 
 
 
Figure S19. Structures and chemical numbering of a) anti-3mC, b) syn-5mC, c) syn-
5hmC, and d) syn-5fC. The glycosidic bond orientation is defined by the χ dihedral 
angle (blue, ∠(O4′C1′N1C2)) as anti (180 ± 90°) or syn (0 ± 90°). 
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Figure S20. Distribution of active site water (red spheres) during MD simulations of a) 
ALKBH2 bound to syn-5hmC, b) ALKBH2 bound to syn-5fC, c) AlkB bound to syn-
5hmC, or d) AlkB bound to syn-5fC. Key hydrogen-bonding interactions are 
highlighted with dashed lines.  
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Figure S21. Simulations of ALKBH2 or AlkB bound to 5hmC.  a) ALKBH2 bound to 
syn-5hmC, and AlkB bound to syn-5hmC with b) θ (∠(C4C5C7O7)) ~ –132° and c) θ 
~ 50°, highlighting different orientations of the C5 substituent. d) Histogram displaying 
the occupancy of θ (degree) during simulations of ALKBH2 or AlkB bound to 5hmC.  
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Figure S22. syn-5fC Bound by a) ALKBH2 or b) AlkB, highlighting the distance 
between the C5 substituent and the Fe(IV)-oxo moiety. 
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Figure S23. Different alkyl DNA modifications oxidized by the three AlkB family 
enzymes at various time points.  Top: AlkB; middle: ALKBH2; and bottom: ALKBH3.  
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Table S1.  Calculated and observed monoisotopic molecular weight and m/z value of 
modified oligonucleotides. The sequence of the 16mer was 5’-
GAAGACCTXGGCGTCC-3’, where X indicates the position of 5mC or oxidized bases.  
modification 
MW 
(calculated) 
of neutral 
species 
m/z 
(calculated) 
-3 charge 
peak 
m/z (observed) -3 charge peak 
5mC 
control ALKBH2 ALKBH3 AlkB 
5mC 4878.866 1625.281 1625.281 1625.279 1625.285 1625.276 
5mC + Na+ 4900.848 1632.608 1632.608 1632.616 1632.613 1632.608 
5mC + K+ 4916.822 1637.933 1637.928 1637.941 1637.942 1637.931 
5mC + 2Na+ 4922.830 1639.935 1639.941 1639.937 1639.938 1639.931 
5mC + Na+ + K+ 4938.803 1645.260 1645.267 1645.273 1645.261 1645.263 
5hmC 4894.861 1630.612 - 1630.615 1630.607 1630.603 
5hmC + Na+ 4916.843 1637.940 - 1637.941 1637.942 1637.931 
5hmC + K+ 4932.816 1643.264 - 1643.265 1643.259 1643.262 
5fC 4892.845 1629.940 - 1629.936 1629.951 1629.933 
5fC + Na+ 4914.827 1637.268 - 1637.288 1637.285 1637.257 
5fC + 2Na+ 4936.809 1644.595 - 1644.605 1644.588 1644.598 
5caC + Na+ 4930.814 1642.600 - 1642.616 1642.611 1642.604 
 
  
 146 
 
Table S2.  Calculated and observed monoisotopic molecular weight and m/z value of 
peptide fragments digested by trypsin.   
peptide 
sequence 
MW 
(calculated) 
of neutral 
species 
m/z 
(calculated) 
+1 charge 
peak 
m/z (observed) +1 charge peak 
AlkB 
wt 
AlkB 
D133A 
AlkB 
H131A 
AlkB 
H187A 
LSLHQDK 839.450 840.457 840.470 - - 840.470 
LSLHQAK 795.460 796.468 - 796.480 - - 
LSLAQDK 773.428 774.436 - - 774.449 - 
LFYHGIQPLK 1214.681 1215.688 1215.706 1215.706 1215.706 - 
LFYAGIQPLK 1148.659 1149.667 - - - 1149.681 
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Table S5. Summary of important distances and dihedral angles adopted during MD 
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the 
ALKBH2 complex. 
 3mC anti-5mC syn-5mC syn-5hmC syn-5fC 
 Avg (σ) Avg (σ) Avg (σ) Avg (σ) Avg (σ) 
Fe(IV)–oxo···C(C7)a 3.3 (0.2) 5.3 (0.5) 3.8 (0.3) 4.5 (0.8) 3.2 (0.4) 
Fe(IV)–
oxo···C(H71)a 3.2 (0.7) 5.5 (0.8) 3.6 (0.6) 4.7 (1.1) 3.3 (0.4) 
Fe(IV)–
oxo···C(H72)a 3.2 (0.6) 5.5 (0.8) 3.6 (0.6) 6.9 (0.6) N/A 
Fe(IV)–
oxo···C(H73)a 3.2 (0.7) 5.5 (0.8) 3.6 (0.6) 3.2 (1.4) N/A 
C(χ)b –147 (15) –143 (19) 49 (11) -9 (17) -19 (19) 
aModification of either N3 (3mC; Figure S19) or C5 (5mC, 5hmC, or 5fC; Figure S19). bχ of bound 
pyrimidine defined as ∠(O4′C1′N1C2) (Figures S18 and S19). 
 
 
Table S6. Summary of important distances and dihedral angles adopted during MD 
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the AlkB 
complex. 
 3mC anti-5mC syn-5mC syn-5hmC syn-5fC 
 Avg (σ) Avg (σ) Avg (σ) Avg (σ) Avg (σ) 
Fe(IV)–oxo···C(C7)a 3.3 (0.2) 7.9 (2.0) 3.6 (0.4) 3.4 (0.2) 3.5 (0.4) 
Fe(IV)–oxo···C(H71)a 3.5 (0.7) 8.2 (2.0) 3.6 (0.7) 3.3 (0.6) 3.8 (0.5) 
Fe(IV)–oxo···C(H72)a 3.4 (0.7) 8.2 (2.0) 3.5 (0.7) 5.8 (0.4) N/A 
Fe(IV)–oxo···C(H73)a 3.4 (0.7) 8.2 (2.0) 3.6 (0.7) 3.3 (1.5) N/A 
C(χ)b –128 (11) –116 (13) 32 (17) 44 (18) 51 (10) 
aModification of either N3 (3mC; Figure S19) or C5 (5mC, 5hmC, or 5fC; Figure S19). bχ of bound 
pyrimidine defined as ∠(O4′C1′N1C2) (Figures S18 and S19). 
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Table S7. Time to half maximum conversion (T1/2, min) for the oxidation of different 
alkyl DNA modifications by the three AlkB family enzymes.   
 1mA 3mC 5mC 3mT 1mG 
AlkB < 1.0 < 1.0 16.9 17.4 1.7 
ALKBH2 < 1.0 < 1.0 17.2 18.7 16.4 
ALKBH3 < 1.0 < 1.0 25.2 30.0 30.7 
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ABSTRACT 
Bulky organic carcinogens are activated in vivo and subsequently react with nucleobases 
of cellular DNA to produce adducts. Some of these DNA adducts exist in multiple 
conformations that are slowly interconverted to one another. Different conformations 
have been implicated in different   mutagenic and repair outcomes. However, studies on 
the conformation-specific inhibition of replication, which is more relevant to cell 
survival, are scarce, presumably due to the structural dynamics of DNA lesions at the 
replication fork. It is difficult to capture the exact nature of replication inhibition by 
existing end-point assays, which usually detect either the ensemble of consequences of 
all the conformers or the culmination of all cellular behaviors, such as mutagenicity or 
survival rate. We previously reported very unusual sequence-dependent conformational 
heterogeneities involving FABP-modified DNA under different sequence contexts 
(TG1*G2T [67%B:33%S] and TG1G2*T [100%B], G*, N-(2′-deoxyguanosin-8-yl)-4′-
fluoro-4-aminobiphenyl) (Cai et al. Nucleic Acids Research, 46, 6356-6370 (2018)). In 
the present study, we attempted to correlate the in vitro inhibition of polymerase activity 
to different conformations from the single FABP-modified DNA lesion. We utilized a 
combination of surface plasmon resonance (SPR) and HPLC-based steady-state kinetics 
to reveal the differences in terms of binding affinity and inhibition with polymerase 
between these two conformers (67%B:33%S and 100%B).  
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KEYWORDS  
4-aminobiphenyl; bulky DNA lesion, conformational heterogeneity, surface plasma 
resonance (SPR) binding kinetics; steady state enzyme kinetics, Klenow fragment 
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INTRODUCTION 
The human genome is under constant assault from the environment. DNA-damage-
induced mutations are known to trigger chemical carcinogenesis [1-5]. Therefore, 
understanding the biological responses of cells to DNA mutations is important. 
Arylamines belong to a notorious group of environmental mutagens/carcinogens that 
produce bulky DNA adducts in vivo [6-10]. They are known to adopt different unique 
conformational motifs: the major groove B-type (B), stacked (S) (Figure 1a) [11], or the 
minor groove wedge (W) [12]. Consequently, these bulky-lesion induced 
conformational heterogeneities complicate mutational and repair outcomes [9-11, 13-
15].  
4-Aminobiphenyl (ABP) is a major etiological agent of human bladder carcinogen 
and a potent urinary-bladder carcinogen in experimental animals. As such, commercial 
production of ABP is banned, however, exposure to ABP can still take place from 
cigarette smoke. ABP is activated by cellular N-acetyltransferase to produce dG-C8-
substituted adduct as a major DNA lesion (dG-C8-ABP, Figure 1b) [12, 16-20]. The 
majority of human bladder cancer has a mutation in the p53 gene. Compared with other 
cancers, the ABP-induced mutations are more evenly distributed along the p53 gene and 
the mutation hotspots occur at both CpG, such as codons 175, 248, and 273, and non-
CpG sites, such as codons 280 and 285, the latter two being unique mutational hotspots 
for bladder and other urinary tract cancers [21]. The major induced mutation was is G 
to T transversion mutation.  Translesion synthesis (TLS) over dG-C8-ABP in two 
different sequences (CCG*GAGGC and CCGGAG*GCC, G*=dG-C8-ABP), which 
represent codon 248 and 249 sequences of the human p53 tumor suppressor gene, 
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respectively, has confirmed that codon 248 is both hot spot of ABP adduct formation 
and G to T mutation [22]. These results suggest that the efficiency of TLS over dG-C8-
ABP is influenced by the surrounding DNA sequences. The structurally similar liver 
carcinogens 2-aminofluorene (AF) and N-2-acetylaminofluorene (AAF) produce 
similar C8-dG adducts. AF could be error-free by correctly base pairing with an 
incoming dC, whereas AAF blocks the replication process and requires recruitment of 
lesion bypass polymerases for TLS. In Escherichia coli, the TLS of AF produces point 
and frameshift mutations, whereas bypass of the AAF lesion is frequently accompanied 
by a frameshift mutation.  
 
Figure 1. (a) Two major conformational views of dG-C8-FABP [N-(2′-deoxyguanosin-
8-yl)-4′-fluoro-4-aminobiphenyl]: B-, and S-conformers. FABP-red, modified dG-blue, 
complementary C-orange. (b) The chemical structure of dG-C8-FABP. 
 
Our previous structural studies showed that fully paired duplexes containing the 
fluorine containing model dG-C8-FABP (fluorine-labeled ABP, FABP, N-(2′-
deoxyguanosin-8-yl)-4′-fluoro-4-aminobiphenyl) adopted a 67%:33% mixture of the B- 
and S-conformers in the TG1*G2T (G*=FABP) sequence context at 25 °C [23]. 
Meanwhile, the same lesion in the TG1G2*T context exhibited exclusively the B-type 
conformation under identical experimental condition. When a replication polymerase 
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encounters a bulky DNA lesion, the polymerase is likely to stall thus stopping DNA 
synthesis. The lesion also influences whether the DNA replication will be error-free or 
error-prone. The aforementioned striking sequence effect in buffer systems warrants 
systematic studies in the presence of a polymerase. Vaidyanathan et al. [24] probed the 
sequence effect of dG-C8-AF (AF, aminofluorene), a structural analog of ABP, on 
nucleotide insertion efficiencies catalyzed by the Klenow fragment (Kf-exo−) on TG*A 
and CG*A sequences [25-26]. They found that the S conformer of CG*A 
thermodynamically favors the insertion of mutagenic A over non-mutagenic C at the 
lesion site. Xu et al. reported that Kf-exo− is a strong binder to template/primer junctions, 
but with minimal nucleotide selectivity against modified DNA [27]. The sequence-
dependent conformational heterogeneity may play an important role in DNA replication 
and mutation. We hypothesize that different conformations lead to different extents of 
polymerase binding affinities, kinetic behaviors, and replication blocks, ultimately 
resulting in complex toxic and mutational outcomes. Here we conducted surface 
plasmon resonance (SPR) binding experiments and steady-state enzyme kinetics in vitro 
to probe the effect of ABP-induced conformational heterogeneity on DNA replication. 
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RESULTS 
DNA Sequence Systems  
For SPR binding experiments, we constructed two biotinylated hairpin-based template–
primer strands (Figure 2a), 85-mer G1* adduct and 84-mer G2* adduct (G* = dG-C8-
FABP). Specifically, two FABP-modified–biotin–31-mer DNA sequences (TG1*G2T 
and TG1G2*T) were purified by HPLC and characterized individually by enzyme 
digestion/MALDI-MS [27-30] (Figure S1). A 54-mer hairpin DNA was annealed and 
ligated to the biotin–31-mer TG1*G2T oligonucleotide, whereas a 53-mer hairpin DNA 
was ligated to the biotin–31-mer TG1G2*T oligonucleotide. The hairpin structures were 
used to improve the thermal stability of the oligonucleotide duplex during SPR 
experiments and the lesion G1* and G2* adduct were placed at the 21st and 22nd bases, 
respectively, to avoid clash between the polymerase protein and the gold chip surface 
[27, 31-32]. 
For HPLC-based steady-state kinetics experiments, two 16-mer G1* or G2* template 
strands were each annealed to various lengths of complementary strands (8-mer to 11-
mer) to create n-3, n-2, n-1, and n for the G1* adduct and n-2, n-1, n, and n+1 for G2* 
(n is the lesion site) (Figure 3a and 3b) [23, 33-35]. 
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Figure 2. (a) Hairpin template−primer oligonucleotide constructs of 85-mer G1 and 84-
mer G2 for Kf-exo−, H denotes 3’-dideoxy-nucleotide; (b) Sensorgrams of binary 
complexes of Kf-exo− with 85-mer and 84-mer unmodified control, G1-FABP and G2-
FABP modified sequences (1:1 binding fitted curves are overlaid as black lines); (c) Ka 
(Ka-modified / Ka-contol) and Kd (Kd-modified / Kd-contol) ratio, G1 and G2 represent 
the ratio of 85-mer FABP-G1/85-mer-control and 84-mer FABP-G2/84-mer-control, 
respectively. 
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Figure 3. DNA replication models for (a) FABP-modified G1* (TG*GT) templates and 
(b) FABP-modified G2* (TGG*T) templates. n: lesion site. Lineweaver–Burk model of 
DNA synthesis catalyzed by Kf-exo− at (c) 10-mer, G1-FABP and (d) 9-mer G2-FABP 
lesion sites with dCTP at steady-state.  The G1-FABP against with Kf–exo– adopted a 
competitive inhibitor model, whereas the behavior of TG1G2*T showed as non-
competitive (see text). 
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Oligonucleotide Characterization by MALDI-TOF MS (Matrix-Assisted Laser 
Desorption/ Ionization-Time of Flight Mass Spectrometry)  
The FABP-modified biotin–31-mer oligonucleotides were characterized by 
exonuclease enzyme digestion followed by MALDI-TOF MS analysis in accordance 
with the published procedures [27, 36]. In the present case, 5′-3′ exonuclease digestion 
on DNA was difficult to carry out due to the binding hindrance of 5’-biotin motif to the 
enzyme. Figure S1b shows the MALDI-TOF MS spectra of the 3′-5′ snake venom 
phosphodiesterase (SVP) exonuclease digestions of the biotin–31-mer G1* adduct at 
different time points (0, 1, 4, 6, 7, 8, and 10 min). The m/z of 9,804 (theoretical 9,803) 
at 0 min represents the control mass-to-charge ratio. Within 6 min of 3′-5′ exonuclease 
digestion, the lower masses appeared corresponding to the 27-mer to 21-mer fragments. 
The m/z = 6,788 (theoretical 6,787) fragment, which persisted from 6 min to 10 min 
was assigned to the G1*-FABP-modified 21-mer. These results confirm the first eluting 
peak (peak 1) from the HPLC profile (Figure S1a) is biotin–31-mer TG1*G2T. Figure 
S1c presents the MALDI-TOF MS spectra of the peak 2 on HPLC with 3′-5′ 
exonuclease digestions. The digestions were fast in the first 4 min showing the m/z 
range from 9,803 to 7,116. However, the digestion stalled from 4-10 min at m/z 7,116, 
which corresponds to the 22-mer fragment containing the FABP-modified guanine 
(theoretical m/z = 7,116). These results confirm that peak 2 is G2*-FABP-modified 
biotin–31-mer.  
The 84- and 85-mer biotinylated oligonucleotides were purified and identified by 
15% denaturing polyacrylamide gel (Hercules, CA) [27]. Figure S2 reveals the 
denaturing gel profiles of unmodified/modified 84- and 85-mer ligated oligonucleotides, 
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biotin–31-mer, and 53-mer/54-mer non-ligated oligonucleotides. For the 85-mer control, 
all the biotin–31-mer and 54-mer hairpins were ligated. As for the 84-mer control, 85-
mer G1*, and 84-mer G2*, excessive biotin–31-mer, 54-mer, and 53-mer were observed 
correspondingly. The ligated and purified 85-mer control/ G1* and 84-mer control/ G2* 
were used for SPR experiments.  
 
HPLC-based Steady-state Kinetics 
We conducted steady-state experiments to investigate the impact of conformational 
heterogeneity on nucleotide insertion kinetics [37]. The E. coli exonuclease-deficient 
Kf-exo− was used for single-nucleotide incorporation. Although the modified base could 
pair with dCTP to complete the primer extension reaction induced by Kf-exo−, the 
reaction efficiency was much poorer than the regular DNA template. The change of 
efficiency is represented by the enzyme kinetic parameters, Km and kcat, and the results 
are summarized in Table 1. The bulky C8 adduct on guanine does not directly block the 
Watson-Crick base pairing, but it could either physically interfere with the dNTP 
binding pocket in Kf-exo− when the FABP-G holds an “S” conformation; or distort Kf-
exo− structure in the ternary complexes and influence the geometry at the active site of 
forming phosphodiester bonds when FABP-G holds the “B” conformation (Figure 1a). 
In both scenarios, the bulky adduct acts as an inhibitor, but in two different ways (Figure 
3). In order to apply the inhibition kinetic model, the whole primer extension assay was 
performed by maintaining the concentration of inhibitor (FABP-containing DNA 
duplex), and varying the concentration of substrate, dNTP (dCTP or dATP). dATP was 
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added to 16/8-mer and 16/11-mer systems, whereas dCTP was added to 16/9-mer and 
16/10-mer sequences (Figure 3).  
dCTP Incorporation: Specifically, adding dCTP to the n-1 (16/10-mer) G1* adduct 
elongated a single 11-mer (Figure 3a), whereas the n-1 (16-/9-mer) G2* adduct produced 
10- and 11-mer (Figure 3b). The formation of 10- and 11-mer mixture from the G2* 
adduct sequence was difficult to quantify; thus, the reduction of the starting material 9-
mer was employed to determine the kinetic parameters for both G1* and G2* reactions. 
The n-1 (16/9-mer) G2* adduct shows a Km value (5.7 µM) similar to that of the 
control (5.8 µM); such similarity indicates an almost equal affinity (Table 1). However, 
the insertion efficiency fins of dCTP opposite –G2* is 4-fold lower than that of the 
unmodified control (0.24 :1) (Table 1). By contrast, the Km of the G1* adduct shows a 
lower affinity (23.4 µM) than that of the control (7.4 µM). The insertion efficiency fins 
in G1* is three times lower than the control (0.33 to 1). These two forms of enzyme 
inhibition can be clearly shown by the Lineweaver-Burk plot. As shown by the 
Lineweaver–Burke enzyme inhibition model (Figure 3c), the (16/10-mer) G1* adduct 
and its control intersect on the Y-axis and a competitive inhibition behavior is suggested. 
By contrast, the n-1 16/9-mer G2* adduct and its control merge at the x-axis. This 
behavior can be explained as non-competitive inhibition (Figure 3d). When the n-1 
(16/9-mer) G2* adduct elongated to 10-mer (n) and 11-mer (n+1), few 10-mer primers, 
but most of the 11-mer primers, were observed from the HPLC profile. This result was 
achieved because the bulky FABP on the G2 at the lesion site (n) does not block the 
replication from n-1 to n+1. 
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Table 1. Steady-state kinetic parameters for insertion of dCTP opposite unmodified and 
FABP−dG adduct with Kf-exo− 
Sequence Km (µM) kcat (min-1) kcat/Km (µM-1·min-1) *fins 
FABP-G1 23.4 ± 0.01 29.7 ± 0.63 1.27 0.33 
Control-G1 7.4 ± 0.10 28.8 ± 0.96 3.87 1.00 
FABP-G2 5.7 ± 0.01 5.5 ± 0.11 0.97 0.24 
Control-G2 5.8 ± 0.11 23.2 ± 0.70 4.00 1.00 
*fins= (kcat /Km)modified/(kcat /Km)unmodified control 
 
dATP Incorporation: The long-range lesion effect was examined by initiating the 
primer elongation with a 16/8-mer template/primer that produces n-2 for G2* (Figure 
3b) and n-3 for G1* (Figure 3a). Figure S3a presents the results at 10 min. In the control, 
~70% of the 8-mer was extended to 9-mer. With adduct on G1, ~40% of the 8-mer was 
converted to 9-mer, indicating a moderate pre-lesion effect at G1*. However, G2* 
blocked ~80% of the 8-mer converting to 9-mer, which indicates a much stronger pre-
lesion effect than that of G1*. These results are not surprising because the 8-mer primer 
is closer to the G2* adduct than the G1* adduct. In the 11-mer (Figure S3b), unmodified 
control exhibited 90% of dATP insertion. However, only ~20% of the 11-mer was 
elongated to 12-mer opposite the G1* lesion. This finding indicates a strong post-lesion 
effect. Moreover, only ~55% of the 11-mer was converted to 12-mer in the n+1 for G2*. 
These results suggest significant retardation of insertion close to the lesion site.  
 
Kf-exo− SPR binding Kinetics 
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Binary System—Figure 2b shows the sensorgrams for the binary binding between Kf-
exo− and unmodified controls (85-mer/84-mer TGGT) or modified sequences (85-mer 
TG1*G2T/84-mer TG1G2*T). These sequences represent replication fork for the G1* and 
G2*, respectively. Kf-exo− shows a much stronger binding affinity (KD) to the modified 
85-mer TG1*G2T (8.3-fold) and 84-mer (5.6-fold) TG1G2*T sequences relative to their 
unmodified controls, 85-mer and 84-mer TGGT, respectively (Table 2). The differences 
are more striking in the dissociation rates (85-mer TGGT kd: 0.84 s−1 vs. 85-mer 
TG1*G2T kd: 0.17 s−1; 84-mer TGGT kd: 0.03 s−1 vs. 84-mer TG1G2*T kd: 0.009 s−1). 
There is a substantial difference in Kd ratio (Kd-modified/Kd-control) between G1 and 
G2 (Figure 2c).  By contrast, the Ka ratios of G1 and G2 are close to each other, indicating 
similar association rates. The stabilization energies here specifically measure the 
energies of forming hydrogen bonds between Kf-exo− and DNA sequences [38]. For the 
binary system the net stabilization energies are positive (Table S1) which indicate the 
hydrogen bonds that form between Kf-exo− and modified sequences (85-mer 
TG1*G2T/84-mer TG1G2*T) are stronger than their unmodified controls (85-mer/84-
mer TGGT). It is interesting to note that although only one base length (dC) differed 
between the 84-mer and 85-mer, the binding affinity of the unmodified 84-mer was 
18.2-fold tighter than that of the 85-mer. Similarly, the KD of the 84-mer TG1G2*T is 
12.2-fold greater than that of the 85-mer TG1*G2T.  
Ternary System— dNTP was added to form Klenow ternary complexes. Kf-exo− 
bound tightly to the unmodified controls when the correct dCTP was introduced in the 
ternary system (Figure 4). In the unmodified 85-mer, the binding affinities of dATP, 
dGTP, and dTTP to the 84-mer controls are reduced by 315-, 284-, and 89-fold, 
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respectively, relative to that of dCTP (Table 2). However, nucleotide selectivity is 
significantly decreased for the ternary complexes with FABP-dG adduct. The KD value 
for the 85-mer TG1*G2T is only reduced by ~5-fold in dATP, dGTP, and dTTP than 
that of dCTP. Similar results were obtained for the 84-mer G2* adduct, where binding 
tightness is reduced by ~2-fold in dATP, dGTP, and dTTP compared with that of dCTP. 
Moreover, as in the binary system, slower dissociation rates were observed for the 
unmodified and G2* modified 84-mers. The KD values of dCTP, dATP, dGTP, and 
dTTP in the unmodified and G2* modified 84-mers are smaller than those of the 
unmodified 85-mer (5- and 13-fold smaller in dCTP and dTTP) and G1* modified 85-
mer TG1*G2T (4-, 13-, 10-, and 12-fold smaller in dCTP, dATP, dGTP, and dTTP, 
respectively).  
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Table 2. SPR binding affinities, KD (nM) of unmodified (TG1G2T) and FABP−dG 
adducts (TG1[FABP]G2T and TG1G2[FABP]T) with Kf-exo− (steady-state affinity 
analysis) in the binary and ternary systems. Association and dissociation rate constants, 
ka and kd, in binary system are listed. 
Sequence Binary KD of Ternary (nM) 
 ka (1/Ms) 
x107 kd (1/s) KD (nM) dCTP dATP dGTP dTTP 
85-mer 
TG1*G2T 
15.90 
(0.17)# 
0.170 
(0.002) 
1.050 
(0.050) 
0.200 
(0.060) 
1.17 
(0.04) 
1.08 
(0.07) 
1.08 
(0.08) 
85-mer 
control 
9.59 
(0.05) 
0.840 
(0.004) 
8.740 
(0.030) 
0.022 
(0.001) 
14.90 
(5.00) 
11.40 
(4.20) 
5.14 
(0.74) 
84-mer 
TG1G2*T 
11.10 
(0.07) 
0.009 
(0.000) 
0.086 
(0.001) 
0.045 
(0.006) 
0.09 
(0.00) 
0.11 
(0.00) 
0.09 
(0.01) 
84-mer 
control 
6.33 
(0.04) 
0.030 
(0.002) 
0.480 
(0.030) 
0.004 
(0.000) 
1.39 
(0.02) 
1.25 
(0.01) 
0.39 
(0.04) 
#standard deviation 
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Figure 4. Sensorgrams of the ternary Kf-exo− complexed with (a) 85-mer control, (b) 
85-mer TG1[FABP]G2T, (c) 84-mer control and (d) 84-mer TG1G2[FABP]T sequences 
in the presence of dNTPs (1:1 binding fitted curves are overlaid as black lines).  
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DISCUSSION 
We previously conducted [23] systematic spectroscopic, thermodynamic, and chip 
binding  (19F-NMR, CD, DSC, and SPR) studies for the extension of 16-mer TG1*G2T 
and TG1G2*T (G*=FABP) sequences. These protein free model systems mimic a 
translesion synthesis of the bulky FABP lesion in two very distinctive sequence-
dependent conformational heterogeneities at G1 (67%B:33%S) and G2 (100%B). The 
results indicate that the sequence-dependent conformational complexities appear to 
persist at various elongation positions, including the ss/ds junction. The B-conformer is 
a major thermodynamic stabilizer in duplex settings, whereas the S-conformer is a 
destabilizer. However, the opposite is the case for adduct at the ss/ds junction. In 
particular, the S-conformation promotes lesion stacking with nascent base pairs at the 
replication fork. SPR results reveal that the S-conformation increases the binding 
affinity with the complementary strands in the order of G1* > G2*. In the present work, 
we examined the effects of these unusual sequence effects on Klenow polymerase 
binding (binary and ternary) and nucleotide insertion kinetics. 
 
Improvement on Model Hairpin Oligonucleotide Construction 
We previously reported a construction of biotinylated hairpin-based template–
primer strand for DNA–polymerase SPR binding studies [27, 39-40]. The general 
strategy was to ligate a biotinylated arylamine-modified 31-mer sequence with 52-mer 
hairpin DNA to form an 83-mer hairpin. This was then followed by addition of a ddNTP 
to the 3′-end to prevent potential primer elongation. However, the ddNTP addition step 
was low yielding and the purification of ligated products was difficult. In the present 
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study, we succeeded in direct ligation of a biotinylated modified 31-mer with ddNTP-
containing 53- and 54-mer hairpin DNA. This process improved the yield significantly 
(from ~10% to ~ 30%), and the products were readily separated by HPLC. Also, 
previously, individual dNTPs (100 μM) were mixed with varying concentrations of Kf-
exo– in sample buffers and injected over the surface without any dNTP in the running 
buffer. This would create a complication resulting in two variables, concentrations of 
dNTPs and Kf–exo– [39]. In the present work, we circumvented the complication by 
adding individual dNTP in running buffer and introducing Kf–exo– directly onto the 
chip surface. This system has only one variable, thus increasing the system stability and 
accuracy for the translesion synthesis.  
 
Lesion and Sequence Effects on SPR Binding Affinities and Kinetics 
Tight binding of Kf–exo– with the unmodified dG control was observed when the 
correct nucleotide dCTP was presented in both 85-mer and 84-mer. This result is in a 
good agreement with expectation and shows high nucleotide selectivity (KD dCTP ≪ KD 
dTTP < KD dATP ~ KD dGTP). Meanwhile, a remarkably tighter binding of Kf–exo– was 
found for the FABP-modified sample relative to the control: i.e., the KD of the 85-mer 
G1* and 84-mer G2* interactions are 8.3 and 5.6 fold higher than the corresponding 
unmodified controls, respectively. Adduct-induced tighter binding affinity with Kf–
exo– has been reported [27, 41] and may be due to the interactions between the bulky 
FABP and the nearby hydrophobic amino-acid residues in the active site of the Kf-exo–. 
In the ternary system, nucleotide selectivity is low. In particular, the KD of the dCTP at 
the opposite G1* and G2* are only ~5- and ~2-fold tighter than the incorrect dATP, 
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dGTP, and dTTP, respectively. This is a strong lesion effect. We observed that the usual 
1:1 model SPR simulation did not provide a clean fit of dCTP for G1* in the ternary 
system. It is possible that the present DNA adduct-Kf complex exist in multiple stages 
due to the FABP-induced S/B conformational heterogeneity at G1* replication fork. 
However, in most cases conformational changes in protein are much faster than SPR 
time scale and thus additional studies would be necessary to confirm these possibilities. 
Our HPLC-based steady-state kinetics data indicate competitive inhibition for the 
S/B-conformer replication fork at G1*. In other words, the S/B conformational 
heterogeneity at G1* is inhibitory to replication probably due to some unfavorable clash 
of the bulky FABP lesion with the incoming dCTP in a competitive manner. The 
unfavorable interactions may be caused by the competition of S-conformer with dCTP 
opposite of dG. However, the exclusively B-conformeric G2* accommodates well for 
the incoming dCTP, resulting in non-competitive inhibition. The equal affinity (Km) 
between G2* and its unmodified dG reveals that the B-conformation in the major grove 
may not interfere with the insertion of the correct dCTP. This finding might also explain 
the greater KD of dCTP at G1* over G2* of the SPR results and indicates a weaker 
binding affinity for G1* over G2*. Alternatively, the B-conformer may not interfere with 
the Watson–Crick base pair, but it may alter the native conformations or hinder the 
formation of phosphodiester bond. The S-conformer portion of G1* cannot provide a 
proper Watson–Crick base pair for replication and it may need to convert back to the B-
conformation to be replicated properly. Thus, the S-conformer may function as a 
competitive inhibitor for replication. We observed a competitive-inhibition model for 
G1* but a non-competitive-inhibition model for G2*. These types of intermediate 
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interactions may be a necessary step in the DNA polymerase proofreading process as 
well.  
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MATERIALS AND METHODS  
Model Oligonucleotide DNA sequences.  
FABP-modified 16-mer templates were prepared in accordance with the published 
procedures [42]: Two mono-adducts (d(5′-CTTCTG1*G2TCCTCATTC-3′)) 
(G*=FABP) (G1* adduct) and (d(5′-CTTCTG1G2*TCCTCATTC-3′)) (G2* adduct). 5′-
Biotin-labeled 31-mer oligonucleotides, 5′-phosphorylated and 3′-dideoxy-A 53-mer, 
5′-phosphorylated and 3′-dideoxy-C 54-mer were purchased from IDT (Integrated DNA 
Technologies Inc., Coralville, IA) in desalted form and purified by reverse-phase high-
performance liquid chromatography (RP-HPLC). Kf-exo− (D355A, E357A) was 
purchased from NEB Inc. (Ipswich, MA). All HPLC solvents were purchased from 
Fisher Inc. (Pittsburgh, PA). The modified oligonucleotides were purified by HPLC 
(Thermo Scientific, Madison, WI) on a Phenomenex Luna C18 analytical column (100 
× 46 mm, 3.0 μm) (Phenomenex, Torrance, CA). For the FABP-modified biotinylated 
31-mer sequence, a 0.2 mL/min flow rate was used in a 48 min linear gradient profile 
(2% to 26%, v/v) acetonitrile with 100 mM TEAA buffer (pH 7.0) in mobile phase 
(Figure S1a).  
 
HPLC-based Steady-State Kinetic Analysis 
The extension efficiency of Kf-exo− polymerase opposite G1* and G2* adducts was 
determined by steady-state kinetic experiments as described by published procedures 
[27, 43-45]. All reactions were performed using Kf-exo− (100 nM) and primers (5 µM) 
in NEB buffer 2 (New England Biolabs, MA) at 22 °C. The primers (8-mer to 12-mer) 
were pre-annealed with 6.75 µM FABP-modified or unmodified 16-mer templates by 
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heating up to 70 °C and slowly cooling down to room temperature. Five different 
concentrations of dCTP or dATP (0, 12.5, 25, 50, and 100 µM) were used to initiate 
nucleotide insertion. All reactions were quenched by adding 10mM EDTA followed by 
immediately denaturing at 80 °C. The initial velocity of each reaction within the steady-
state range was then obtained by performing every reaction within a short time period 
from 5 s to 30 s. The extended and unextended primers were separated by anion-
exchange HPLC with a 1.5 M ammonium acetate gradient of 40-60% in water for 6.5 
min and quantified by the absorbance of UV at 260 nm. All reactions were performed 
at 22 °C in triplicate, and the results were analyzed with a GraphPad Prism 5 software 
by using the Lineweaver–Burk model. The inhibition curves were fitted to the equation 
1/V = 1/Vmax + (KM/Vmax)/[SdCTP]. The relative insertion efficiency fins was obtained as 
(kcat /KM)modified/(kcat /KM)unmodified. 
 
SPR Measurements 
FABP-modified Hairpin Template/Primer Constructs. 5′-Biotinylated 31-mer 
containing dG-C8-FABP in the “-TG1G2T-” sequence context was used in SPR analysis 
following the reported procedures [27, 39-40]. The two FABP-modified biotinylated 
31-mer G1* and G2* adducts were separated by RP-HPLC and characterized by 
MALDI-TOF MS [36]. The 84-mer and 85-mer hairpin–template–primer were prepared 
by following the reported protocols [27, 39]. Briefly, two different lengths of hairpin 
DNA sequences (53- and 54-mer) were phosphorylated at their 5′-ends, but their 3′-ends 
were modified with ddA and ddC, respectively, to prevent further primer elongation 
(Figure 2a). The biotinylated 31-mer modified G1* adduct and 54-mer hairpin were 
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desalted by G-25 spin columns and annealed together by heating to 95 °C for 5 min and 
cooling to room temperature. The mixture solution was ligated in a buffer containing 
4,000 units of T4 ligase enzyme for 16 h at room temperature. The resulting 85-mer 
oligonucleotide was purified in 15% denaturing polyacrylamide gel and extracted using 
the electroelution method followed by desalting by again using G-25 spin columns. The 
corresponding biotinylated 85-mer was finally purified by RP-HPLC. G2* adduct 
biotinylated 84-mer and unmodified biotinylated 84- and 85-mers were also prepared 
similarly. All the 84- and 85-mer oligonucleotides were identified by the 15% 
denaturing polyacrylamide gel (Figure S2). 
 
Immobilization of Streptavidin (SA) on CM5 S Chip and DNA Coating.  SPR 
experiments were carried out using Biacore T200 (GE Healthcare, Piscataway, NJ). 
The SA via the amine coupling kit was immobilized on flow cells on the 
carboxymethylated dextran-coated CM5 S chip by following the reported procedures 
[27, 39]. After SA immobilization at around 2,000 RU on the flow cells, the chip 
surface was washed with 50 mM NaOH for 60 s five times to reach below 20 RU. 
Then, the running buffer was injected three times, and the system was equilibrated 
with running buffer for 2 h. The 84- and 85-mer unmodified and modified G1* and 
G2* biotinylated DNA sequences (2 nM) were injected over the flow cells (2 to 4) for 
90-120 s to achieve 5-6 RU. The surface was stabilized with running buffer for 3 h 
before conducting SPR binding affinity experiments. 
 
Real-time Kinetic Analysis by SPR.   
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The SPR system was first primed at least three times with running buffer and zero-
concentration injections to condition the plasmon surface. The DNA was coated on the 
SA surface of flow cell 2 to 4 (cell 1 as blank reference). Surface testing, regeneration 
buffer scouting, and mass transport limitation test were conducted prior to kinetic 
experiments following previous reports [27, 39]. DNA coating around 4-5 RU did not 
show any impact of mass transport. The steady-state affinity analysis of Kf-exo− 
binding to unmodified and modified DNA was analyzed in the absence (binary) and 
presence of dNTPs (ternary) by varying Kf-exo− concentrations. 
For the binary system, Kf-exo− was injected without dNTPs over the DNA surface 
in varying concentrations (0-25 nM) and repeated twice as described previously [27]. 
Briefly, the 1× HBS-P running buffer (containing 100 μg/mL bovine serum albumin 
[BSA] and 5 mM MgCl2) with six different concentrations Kf-exo− (0-25 nM) was 
injected for 30 s at a flow rate of 100 μL/min over the cells. Afterward, 0.05% SDS 
was applied as regeneration solution at a flow rate of 100 μL/min over the surface for 
30 s. The surface was stabilized with running buffer for 15 min after a regeneration 
step between different concentration circles.  
For the ternary system, dNTPs were injected with the HBS-P running buffer for 
comparison. 1× HBS-P running buffer (100 μg/mL BSA, 5 mM MgCl2, and 100 μM 
individual dNTPs) with varying concentrations of Kf-exo− was injected over the 
surface. For both binary and ternary systems, sensorgrams were fitted by using a 1:1 
Langmuir model, and the binding affinity constants (KD) were determined using 
steady-state affinity analysis in the BIA evaluation software v 1.0 provided by the 
manufacturer (GE Healthcare).  
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CONCLUSIONS 
In this paper, we conducted SPR and HPLC-based steady-state kinetics studies to probe 
adduct-induced conformation-dependent replication block during translesion synthesis 
(TLS). The FABP-modified DNA adduct adopts a mixture of B and S conformations in 
the TG1*G2T (67%B:33%S), but shows exclusively B conformation in the TG1G2*T 
sequence context [23]. According to the present Lineweaver–Burk enzyme inhibition 
model, the S/B-conformeric mix G1* adduct exhibits a competitive-inhibition, whereas 
the B-conformeric G2* adduct behaves as a non-competitive inhibitor in the nucleotide 
insertion step. These results indicate that the S-conformer may not be able to 
accommodate the incoming dCTP and exhibits a competitive behavior with incoming 
dNTPs, thus blocking replication. By contrast, the exclusive B-conformer G2* does not 
interfere with the Watson-Crick base pairing, resulting in a proper dCTP insertion. As 
such, the B-conformer shows a non-competitive-inhibition behavior. The SPR binding 
results implicate an adduct-induced tight binding with Kf-exo– in a binary system. In the 
ternary system, nucleotide selectivity decreases when G1 and G2 are modified by FABP. 
From these experiments, we observed the effect of conformational heterogeneity 
induced by bulky lesion on replication block.  
It has been reported that compared with other cancers, the ABP-induced mutations 
are more evenly distributed along the p53 gene and the mutation hotspots occur through 
the genome with the major mutation being G to T transversion [21-22]. TLS over dG-
C8-ABP in two different sequences (CCG*GAGGC and CCGGAG*GCC, G*=dG-C8-
ABP), which represent codon 248 and 249 sequences of the human p53 tumor 
suppressor gene, respectively, has confirmed that codon 248 is a hot spot for adduct 
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formation and G to T mutation. These results suggest that the efficiency of TLS over 
dG-C8-ABP is affected by the surrounding DNA sequences of the ABP lesion, 
consequently the B/S conformational heterogeneity as described here. Elucidation of 
conformation-specific bypass, mutational and repair processes over the ABP adducts in 
cell should clarify the molecular mechanisms underlying ABP-induced mutagenesis and 
carcinogenesis. 
In the present paper, we demonstrated the combination of SPR binding and HPLC 
steady-state kinetics as a power tool in investigating FABP-induced conformational 
heterogeneity in TLS. This approach can be applied to studying other bulky DNA 
adducts. 
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 (a)  
 
 
 
 
 
 
 (b)  
(c)  
Figure S1. HPLC profile of FABP-modified bio-31mer TGGT template and MALDI-
TOF characterization of peak 1 and peak 2. (a) HPLC chromatogram of a reaction 
mixture of biotinylated-31-mer sequence (5'-Bio-CCTCTTCCCTCACCTCTTC 
TG1G2TCCTCATTC-3') with an activated FABP (N-Acetoxy-N-(trifluoroacetyl)-4’-
fluoro-4-aminobiphenyl) and photodiode array UV spectra of unmodified and mono-
adducts. (b) and (c): MALDI-TOF mass spectra of FABP modified biotinylated-31mer-
TGGT. (b) 3’-Exonuclease digestions of peak 1 at 0, 1, 4, 6, 7, 8 and 10min. (c) 3’-
Exonuclease digestions of peak 2 at 0, 1, 4, 6, 7, 8 and 10min. Insets show the theoretical 
MW of the corresponding fragments that should form after 3’-exonuclease digestion. 
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Figure S2. Denaturing gel (15%) profiles of 84-mer and 85-mer ligated 
oligonucleotides, 31-mer, 53-mer and 54-mer non-ligated oligonucleotides.  
 
 
Figure S3. dATP Insertion efficiency of (a) 8-mer to 9-mer and (b) 11-mer to 12-mer 
in control, G1*G2T-FABP and G1G2*T-FABP, respectively, at 10 min (see Figure 3 for 
sequences) 
(a) 
 
 
(b) 
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Table S1. Binding net stabilization energy of unmodified and FABP-adducts with Kf-
exo− in binary system (1:1 binding). 
Sequence kd (1/s) *Net stabilization Energy (kcal/mol) 
85-mer control 0.84 (0.004) 0 
85-mer TG1[FABP]G2T 0.17 (0.002) 0.95 
84-mer control 0.03 (0.002) 0 
84-mer TG1G2[FABP]T 0.009 (0.0001) 0.71 
*Net stabilization energy (kcal/mol)= -RTln(kd)modified – [-RTln(kd)unmodified 
